SCO1

UniProt ID: O75880
Organism: Homo sapiens
Review Status: COMPLETE
📝 Provide Detailed Feedback

Gene Description

SCO1 is an inner mitochondrial membrane copper metallochaperone required for maturation of the CuA site of cytochrome c oxidase subunit II (MT-CO2/COX2). Together with SCO2 and other COX2-module factors, SCO1 participates in the mitochondrial copper relay that enables Complex IV assembly. SCO2 appears to act upstream as a thiol-disulfide oxidoreductase affecting the redox state of SCO1's copper-coordinating cysteines, whereas SCO1 is best treated as the copper-handling/metallochaperone step for COX2 CuA-site maturation. SCO1 is an assembly factor rather than a structural subunit of mature Complex IV. It also has a secondary role in cellular copper homeostasis, including regulation of CTR1 abundance/localization. Pathogenic variants cause mitochondrial Complex IV deficiency, nuclear type 4.

Existing Annotations Review

GO Term Evidence Action Reason
GO:0005507 copper ion binding
IEA
GO_REF:0000002
ACCEPT
Summary: SCO1 binds copper through conserved SCO-family metal-binding residues as part of the mitochondrial copper relay for COX2 CuA-site maturation.
Reason: Core biochemical property supporting copper chaperone activity. The existing annotation is IEA, but patient-cell and pathway-ordering evidence support the functional importance of the CxxxC copper-coordinating motif in SCO1-dependent COX2 maturation.
Supporting Evidence:
PMID:19336478
The subsequent maturation of CO II is contingent upon the formation of a complex that includes both SCO proteins, each with a functional CxxxC copper-coordinating motif.
file:human/SCO1/SCO1-deep-research-falcon.md
SCO1 has a thioredoxin-like fold and a copper-binding CxxxC motif characteristic of SCO-family proteins; available context states that cysteine-based copper binding requires the cysteines to remain reduced.
GO:0005743 mitochondrial inner membrane
IEA
GO_REF:0000120
ACCEPT
Summary: SCO1 is a single-pass mitochondrial inner membrane protein with its functional domain exposed for COX2 maturation.
Reason: Correct core localization.
Supporting Evidence:
file:human/SCO1/SCO1-deep-research-falcon.md
Human SCO1 is described as a mitochondrial inner membrane transmembrane protein with a short N-terminal matrix-facing tail and most of the polypeptide exposed to the IMS, consistent with its role in receiving copper from IMS-localized COX17 and delivering copper to the IMS-facing domain of COX2.
GO:0006878 intracellular copper ion homeostasis
IEA
GO_REF:0000002
KEEP AS NON CORE
Summary: SCO1 participates in copper handling and has reported effects on cellular copper homeostasis, but its primary evolved role is copper delivery during Complex IV assembly.
Reason: Keep as a valid secondary function, not the core annotation. Falcon-summarized 2023-2024 work in hepatocyte-specific Sco1 loss models links SCO1 deficiency to hepatic copper deficiency, elevated circulating copper/ceruloplasmin, and copper-dependent immunosuppression signaling, supporting a real but secondary role in systemic copper homeostasis.
Supporting Evidence:
file:human/SCO1/SCO1-deep-research-falcon.md
2023-2024 work links hepatocyte-specific Sco1 loss to hepatic copper deficiency, elevated circulating copper/ceruloplasmin, AFP-dependent copper-requiring immunosuppression, and bone-marrow lymphoid progenitor defects, expanding SCO1 biology from complex IV metallation to systemic pathophysiology in mitochondrial disease models.
GO:0008535 respiratory chain complex IV assembly
IEA
GO_REF:0000002
ACCEPT
Summary: SCO1 is required for respiratory chain Complex IV assembly through COX2 copper-site maturation.
Reason: Correct biological-process annotation.
Supporting Evidence:
file:human/SCO1/SCO1-deep-research-falcon.md
SCO1 is the COX2-specific copper metallochaperone for cytochrome c oxidase/complex IV biogenesis. Current understanding is that it inserts copper into the CuA site of COX2 rather than catalyzing a classic enzyme reaction; its role is metallation/assembly, with redox competence of cysteines required for function.
GO:0016531 copper chaperone activity
IEA
GO_REF:0000002
ACCEPT
Summary: SCO1 functions as a copper chaperone/metallochaperone in the COX2 CuA-site maturation pathway.
Reason: Core molecular function. OpenScientist review of the focused core-function hypothesis judged this term supported, while highlighting that the current GOA term is IEA-only and should be upgraded or complemented with experimental support from patient-cell studies and pathway-ordering work.
Supporting Evidence:
PMID:15229189
Our results demonstrate that the human SCO proteins have non-overlapping, cooperative functions in mitochondrial copper delivery.
PMID:19336478
Based on these data we present a model in which each SCO protein fulfills distinct, stage-specific functions during CO II synthesis and CuA site maturation.
file:human/SCO1/SCO1-hypotheses/core-function-1-go-0016531/openscientist.md
OpenScientist judged copper chaperone activity (GO:0016531) to be supported as a core molecular function of SCO1 and recommended upgrading the IEA-only molecular-function support.
file:human/SCO1/SCO1-deep-research-falcon.md
Across recent reviews, SCO1 is described as a COX2-specific copper metallochaperone required for insertion of copper into the CuA site of COX2 during complex IV assembly. SCO1 is not described as catalyzing a small-molecule reaction; instead, its functional output is metal delivery/metallation and enabling maturation of complex IV.
GO:0033617 mitochondrial respiratory chain complex IV assembly
IEA
GO_REF:0000117
ACCEPT
Summary: SCO1 participates specifically in mitochondrial respiratory chain Complex IV assembly.
Reason: Correct and appropriately specific biological-process annotation.
Supporting Evidence:
file:human/SCO1/SCO1-deep-research-falcon.md
Recent reviews converge on a mechanistic consensus that SCO1 is a core CuA-site metallochaperone operating at the IMS face of the inner membrane, receiving copper from COX17 and cooperating with SCO2/COA6-driven redox processes to enable copper insertion into COX2 and thus complex IV maturation.
GO:0005515 protein binding
IPI
PMID:18458339
Mitochondrial copper(I) transfer from Cox17 to Sco1 is coupl...
MARK AS OVER ANNOTATED
Summary: The protein-binding annotations report physical interactions among COX2-module assembly factors or broad interactome hits. These do not define SCO1's function.
Reason: Generic protein binding is less informative than copper chaperone activity and Complex IV assembly; mark as over-annotated rather than core.
GO:0005515 protein binding
IPI
PMID:29568061
An AP-MS- and BioID-compatible MAC-tag enables comprehensive...
MARK AS OVER ANNOTATED
Summary: The protein-binding annotations report physical interactions among COX2-module assembly factors or broad interactome hits. These do not define SCO1's function.
Reason: Generic protein binding is less informative than copper chaperone activity and Complex IV assembly; mark as over-annotated rather than core.
GO:0005515 protein binding
IPI
PMID:32296183
A reference map of the human binary protein interactome.
MARK AS OVER ANNOTATED
Summary: The protein-binding annotations report physical interactions among COX2-module assembly factors or broad interactome hits. These do not define SCO1's function.
Reason: Generic protein binding is less informative than copper chaperone activity and Complex IV assembly; mark as over-annotated rather than core.
GO:0005515 protein binding
IPI
PMID:32814053
Interactome Mapping Provides a Network of Neurodegenerative ...
MARK AS OVER ANNOTATED
Summary: The protein-binding annotations report physical interactions among COX2-module assembly factors or broad interactome hits. These do not define SCO1's function.
Reason: Generic protein binding is less informative than copper chaperone activity and Complex IV assembly; mark as over-annotated rather than core.
GO:0005739 mitochondrion
IEA
GO_REF:0000107
ACCEPT
Summary: SCO1 is a mitochondrial Complex IV assembly factor.
Reason: Correct broad localization; mitochondrial inner membrane is more specific.
GO:0005739 mitochondrion
HTP
PMID:34800366
Quantitative high-confidence human mitochondrial proteome an...
ACCEPT
Summary: SCO1 is a mitochondrial Complex IV assembly factor.
Reason: Correct broad localization; mitochondrial inner membrane is more specific.
Supporting Evidence:
file:human/SCO1/SCO1-uniprot.txt
SUBCELLULAR LOCATION: Mitochondrion
GO:0005743 mitochondrial inner membrane
TAS
Reactome:R-HSA-9865449
ACCEPT
Summary: SCO1 is a single-pass mitochondrial inner membrane protein with its functional domain exposed for COX2 maturation.
Reason: Correct core localization.
GO:0005743 mitochondrial inner membrane
TAS
Reactome:R-HSA-9865579
ACCEPT
Summary: SCO1 is a single-pass mitochondrial inner membrane protein with its functional domain exposed for COX2 maturation.
Reason: Correct core localization.
GO:0005743 mitochondrial inner membrane
TAS
Reactome:R-HSA-9865630
ACCEPT
Summary: SCO1 is a single-pass mitochondrial inner membrane protein with its functional domain exposed for COX2 maturation.
Reason: Correct core localization.
GO:0005739 mitochondrion
IDA
PMID:9878253
Identification and characterization of human cDNAs specific ...
ACCEPT
Summary: SCO1 is a mitochondrial Complex IV assembly factor.
Reason: Correct broad localization; mitochondrial inner membrane is more specific.
Supporting Evidence:
file:human/SCO1/SCO1-uniprot.txt
SUBCELLULAR LOCATION: Mitochondrion inner membrane
GO:0005515 protein binding
IPI
PMID:29381136
COX16 promotes COX2 metallation and assembly during respirat...
MARK AS OVER ANNOTATED
Summary: The protein-binding annotations report physical interactions among COX2-module assembly factors or broad interactome hits. These do not define SCO1's function.
Reason: Generic protein binding is less informative than copper chaperone activity and Complex IV assembly; mark as over-annotated rather than core.
GO:0033617 mitochondrial respiratory chain complex IV assembly
IMP
PMID:15229189
Human SCO1 and SCO2 have independent, cooperative functions ...
ACCEPT
Summary: SCO1 participates specifically in mitochondrial respiratory chain Complex IV assembly.
Reason: Correct and appropriately specific biological-process annotation.
Supporting Evidence:
file:human/SCO1/SCO1-deep-research-falcon.md
SCO1 is described as a COX2-specific copper metallochaperone required for insertion of copper into the CuA site of COX2 during complex IV assembly.
GO:0005743 mitochondrial inner membrane
IDA
PMID:15229189
Human SCO1 and SCO2 have independent, cooperative functions ...
ACCEPT
Summary: SCO1 is a single-pass mitochondrial inner membrane protein with its functional domain exposed for COX2 maturation.
Reason: Correct core localization.
Supporting Evidence:
file:human/SCO1/SCO1-deep-research-falcon.md
Human SCO1 is described as a mitochondrial inner membrane transmembrane protein with a short N-terminal matrix-facing tail and most of the polypeptide exposed to the IMS
GO:0005515 protein binding
IPI
PMID:24403053
Human COX20 cooperates with SCO1 and SCO2 to mature COX2 and...
MARK AS OVER ANNOTATED
Summary: The protein-binding annotations report physical interactions among COX2-module assembly factors or broad interactome hits. These do not define SCO1's function.
Reason: Generic protein binding is less informative than copper chaperone activity and Complex IV assembly; mark as over-annotated rather than core.
GO:0005515 protein binding
IPI
PMID:28330871
Human mitochondrial cytochrome c oxidase assembly factor COX...
MARK AS OVER ANNOTATED
Summary: The protein-binding annotations report physical interactions among COX2-module assembly factors or broad interactome hits. These do not define SCO1's function.
Reason: Generic protein binding is less informative than copper chaperone activity and Complex IV assembly; mark as over-annotated rather than core.
GO:0005515 protein binding
IPI
PMID:29154948
The mitochondrial TMEM177 associates with COX20 during COX2 ...
MARK AS OVER ANNOTATED
Summary: The protein-binding annotations report physical interactions among COX2-module assembly factors or broad interactome hits. These do not define SCO1's function.
Reason: Generic protein binding is less informative than copper chaperone activity and Complex IV assembly; mark as over-annotated rather than core.
GO:0005515 protein binding
IPI
PMID:26160915
COA6 is a mitochondrial complex IV assembly factor critical ...
MARK AS OVER ANNOTATED
Summary: The protein-binding annotations report physical interactions among COX2-module assembly factors or broad interactome hits. These do not define SCO1's function.
Reason: Generic protein binding is less informative than copper chaperone activity and Complex IV assembly; mark as over-annotated rather than core.
GO:0030016 myofibril
IDA
PMID:20864674
Unexpected vascular enrichment of SCO1 over SCO2 in mammalia...
KEEP AS NON CORE
Summary: The myofibril annotation reflects reported localization/enrichment in a tissue context but does not describe SCO1's primary mitochondrial assembly-factor role.
Reason: Keep as non-core pending stronger mechanistic interpretation.

Core Functions

SCO1 is a mitochondrial copper chaperone/assembly factor that helps deliver copper to the CuA site of MT-CO2 during Complex IV biogenesis. Its core function is not mature Complex IV catalysis, but copper handling within the COX2 maturation pathway. Evidence from SCO1 and SCO2 patient-cell studies supports distinct, stage-specific roles: SCO2 acts upstream in CO II synthesis/redox control, while SCO1 is required for the copper-dependent maturation step.

Supporting Evidence:
  • PMID:15229189
    Our results demonstrate that the human SCO proteins have non-overlapping, cooperative functions in mitochondrial copper delivery.
  • PMID:19336478
    Based on these data we present a model in which each SCO protein fulfills distinct, stage-specific functions during CO II synthesis and CuA site maturation.
  • file:human/SCO1/SCO1-hypotheses/core-function-1-go-0016531/openscientist.md
    The focused OpenScientist hypothesis review found the SCO1 copper chaperone core-function hypothesis supported and identified IEA-only GO:0016531 support as the main curation gap.
  • file:human/SCO1/SCO1-uniprot.txt
    Copper metallochaperone essential for the maturation of cytochrome c oxidase subunit II (MT-CO2/COX2). Together with SCO2, involved in delivering copper to the Cu(A) site on MT-CO2/COX2.
  • file:human/SCO1/SCO1-deep-research-falcon.md
    Across recent reviews, SCO1 is described as a COX2-specific copper metallochaperone required for insertion of copper into the CuA site of COX2 during complex IV assembly. SCO1 is not described as catalyzing a small-molecule reaction; instead, its functional output is metal delivery/metallation and enabling maturation of complex IV.
  • file:human/SCO1/SCO1-deep-research-falcon.md
    Human SCO1 is described as a mitochondrial inner membrane transmembrane protein with a short N-terminal matrix-facing tail and most of the polypeptide exposed to the IMS, consistent with its role in receiving copper from IMS-localized COX17 and delivering copper to the IMS-facing domain of COX2.

References

Gene Ontology annotation through association of InterPro records with GO terms
Automatic transfer of experimentally verified manual GO annotation data to orthologs using Ensembl Compara
Electronic Gene Ontology annotations created by ARBA machine learning models
Combined Automated Annotation using Multiple IEA Methods
Human SCO1 and SCO2 have independent, cooperative functions in copper delivery to cytochrome c oxidase.
Human SCO2 is required for the synthesis of CO II and as a thiol-disulphide oxidoreductase for SCO1.
  • SCO2 acts upstream of SCO1 and is required for CO II synthesis.
  • SCO1 and SCO2 fulfill distinct, stage-specific functions during CO II synthesis and CuA site maturation.
  • The redox state of SCO1 copper-coordinating cysteines is perturbed in SCO1 and SCO2 patient-cell backgrounds.
file:human/SCO1/SCO1-hypotheses/core-function-1-go-0016531/openscientist.md
OpenScientist focused review of SCO1 copper chaperone activity as a core function
  • The SCO1 copper chaperone activity core-function hypothesis was judged supported.
  • The current GO:0016531 annotation is biologically correct but IEA-only in GOA.
  • PMID:15229189 and PMID:19336478 were prioritized as evidence for experimental support of SCO1 copper handling in COX2 maturation.
  • SCO2 should be considered for a separate follow-up audit because its direct role may be better described as upstream thiol-disulfide oxidoreductase activity.
Mitochondrial copper(I) transfer from Cox17 to Sco1 is coupled to electron transfer.
Unexpected vascular enrichment of SCO1 over SCO2 in mammalian tissues: implications for human mitochondrial disease.
Human COX20 cooperates with SCO1 and SCO2 to mature COX2 and promote the assembly of cytochrome c oxidase.
COA6 is a mitochondrial complex IV assembly factor critical for biogenesis of mtDNA-encoded COX2.
Human mitochondrial cytochrome c oxidase assembly factor COX18 acts transiently as a membrane insertase within the subunit 2 maturation module.
The mitochondrial TMEM177 associates with COX20 during COX2 biogenesis.
COX16 promotes COX2 metallation and assembly during respiratory complex IV biogenesis.
An AP-MS- and BioID-compatible MAC-tag enables comprehensive mapping of protein interactions and subcellular localizations.
A reference map of the human binary protein interactome.
Interactome Mapping Provides a Network of Neurodegenerative Disease Proteins and Uncovers Widespread Protein Aggregation in Affected Brains.
Quantitative high-confidence human mitochondrial proteome and its dynamics in cellular context.
Identification and characterization of human cDNAs specific to BCS1, PET112, SCO1, COX15, and COX11, five genes involved in the formation and function of the mitochondrial respiratory chain.
Reactome:R-HSA-9865449
Metallochaperone inserts Cu2+ into MT-CO1
Reactome:R-HSA-9865579
MT-CO1 and MT-CO2 complexes associate, installing heme moieties
Reactome:R-HSA-9865630
Metallochaperone inserts 2Cu2+ into MT-CO2
file:human/SCO1/SCO1-deep-research-falcon.md
Falcon (Edison) deep-research report on human SCO1 (O75880)
  • SCO1 is the COX2-specific copper metallochaperone required for insertion of copper into the CuA site of COX2 during complex IV assembly; its functional output is metal delivery/metallation, not catalysis of a small-molecule reaction.
    "Across recent reviews, SCO1 is described as a COX2-specific copper metallochaperone required for insertion of copper into the CuA site of COX2 during complex IV assembly. SCO1 is not described as catalyzing a small-molecule reaction; instead, its functional output is metal delivery/metallation and enabling maturation of complex IV."
  • Human SCO1 is an inner mitochondrial membrane protein with a short N-terminal matrix-facing tail and the bulk of the polypeptide exposed to the IMS, positioning its functional domain for COX2 CuA-site maturation.
    "Human SCO1 is described as a mitochondrial inner membrane transmembrane protein with a short N-terminal matrix-facing tail and most of the polypeptide exposed to the IMS, consistent with its role in receiving copper from IMS-localized COX17 and delivering copper to the IMS-facing domain of COX2."
  • SCO1 has a thioredoxin-like fold and a conserved CxxxC copper-binding motif; cysteine-based copper binding requires the cysteines to remain reduced.
    "SCO1 has a thioredoxin-like fold and a copper-binding CxxxC motif characteristic of SCO-family proteins; available context states that cysteine-based copper binding requires the cysteines to remain reduced."
  • SCO2 and COA6 act as disulfide reductases/thiol-redox factors that keep SCO1 (and/or COX2) in a copper-binding competent state, coupling redox and copper handling.
    "The IMS copper-handling network requires redox regulation: SCO2 and COA6 are described as acting as disulfide reductases/thiol-redox factors that maintain SCO1 (and/or COX2) in a copper-binding competent state."
  • A current model proposes that SCO1 and SCO2 can form a ternary complex with apo-COX2 in which each SCO protein donates a single copper ion to build the binuclear CuA center.
    "A recent synthesis emphasizes that in humans SCO1 and SCO2 can form a ternary complex with apo-COX2, with each SCO protein proposed to donate a single copper ion to build the binuclear CuA center."
  • Mechanistic consensus places SCO1 at the IMS face of the inner membrane, receiving copper from COX17 and cooperating with SCO2/COA6-driven redox processes to enable copper insertion into COX2 and Complex IV maturation.
    "Recent reviews converge on a mechanistic consensus that SCO1 is a core CuA-site metallochaperone operating at the IMS face of the inner membrane, receiving copper from COX17 and cooperating with SCO2/COA6-driven redox processes to enable copper insertion into COX2 and thus complex IV maturation."
  • SCO1 deficiency causes severe neonatal/infantile mitochondrial disease with isolated/predominant complex IV deficiency, including hypertrophic cardiomyopathy, hepatic failure, encephalopathy/brain atrophy, and lactic acidosis; reported variants include V93X, G132S, P174L, and M294V.
    "Human SCO1 deficiency causes severe neonatal/infantile mitochondrial disease with isolated or predominant complex IV deficiency. Reported phenotypes include neonatal hepatic failure, lactic acidosis, hypertrophic cardiomyopathy/ventricular hypertrophy, hepatomegaly, encephalopathy/brain atrophy, and fatal infantile cardio-hepatic-neurologic disease. Variants reported in context include V93X, G132S, P174L, and M294V."
  • The P174L pathogenic variant lies adjacent to the copper-binding region and, in yeast modeling, impairs copper transfer from COX17 despite preserved copper binding, consistent with a defect in copper handoff rather than complete loss of copper binding.
    "For example, the P174L variant is described as adjacent to the copper-binding region and, in yeast modeling, it impairs copper transfer from COX17 despite normal copper binding, supporting a specific defect in copper handoff rather than complete loss of copper binding."
  • 2023-2024 work in hepatocyte-specific Sco1 loss models links SCO1 deficiency to hepatic copper deficiency, elevated circulating copper/ceruloplasmin, AFP-dependent copper-requiring immunosuppression, and bone-marrow lymphoid progenitor defects, extending SCO1 biology from local Complex IV metallation to systemic copper-linked signaling.
    "2023-2024 work links hepatocyte-specific Sco1 loss to hepatic copper deficiency, elevated circulating copper/ceruloplasmin, AFP-dependent copper-requiring immunosuppression, and bone-marrow lymphoid progenitor defects, expanding SCO1 biology from complex IV metallation to systemic pathophysiology in mitochondrial disease models."

Suggested Questions for Experts

Q: Should GO add or request an experimental human SCO1 annotation to GO:0016531 based on PMID:15229189 and PMID:19336478, rather than leaving the molecular-function support as IEA-only?

Q: Does the evidence for SCO2 support retaining copper chaperone activity, or should SCO2 be reviewed separately as an upstream thiol-disulfide oxidoreductase acting on SCO1?

Q: Is there direct human biochemical evidence for copper transfer from purified SCO1 to a COX2 CuA-site substrate, or should SCO1 copper chaperone activity remain supported primarily by IMP/pathway-ordering evidence?

Suggested Experiments

Experiment: Reconstitute copper transfer from purified human SCO1 to a COX2 CuA-site substrate or COX2 maturation module, with CxxxC/His-site mutants as negative controls.

Hypothesis: SCO1 directly transfers copper to the COX2 CuA-site maturation intermediate.

Type: in vitro copper-transfer assay

Experiment: Perform rescue experiments in SCO1-deficient human cells with wild-type SCO1 and copper-coordinating motif mutants, measuring COX2 metallation, Complex IV assembly, and COX activity separately.

Hypothesis: SCO1's copper-coordinating motif is required for COX2 metallation rather than only for SCO1 stability or protein-protein interaction.

Type: CRISPR rescue and mitochondrial biogenesis assay

Deep Research

Falcon

(SCO1-deep-research-falcon.md)
Research Report: Human **SCO1** (UniProt **O75880**) — Functional Annotation, Mechanism, and Disease Relevance Falcon Edison Scientific Literature 25 citations 2 artifacts 2026-05-30T00:37:51.885085

The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.

You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.

We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.

We are interested in where in or outside the cell the gene product carries out its function.

We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.

Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.

Research Report: Human SCO1 (UniProt O75880) — Functional Annotation, Mechanism, and Disease Relevance

1) Target verification (mandatory)

The target is human SCO1 (UniProt O75880), annotated as Cytochrome c oxidase assembly factor SCO1, a member of the SCO1/2 family involved in mitochondrial complex IV (cytochrome c oxidase, COX) biogenesis. Recent authoritative reviews explicitly describe human SCO1 (hSCO1) as a mitochondrial inner membrane protein with its major functional region facing the intermembrane space (IMS) and functioning in CuA-site copper insertion into COX2, which matches the UniProt description and the SCO1/SenC domain-family expectations. (guaragnella2024morethanjust pages 13-14, garza2023mitochondrialcopperin pages 4-6)

2) Key concepts and definitions (current understanding)

Cytochrome c oxidase (Complex IV) and copper centers

Cytochrome c oxidase (COX; complex IV) is the terminal oxidase of the mitochondrial respiratory chain. Proper function requires metal cofactors, including copper centers. One key copper site is the CuA center located in the COX2 subunit; assembly of this site requires dedicated accessory proteins (“assembly factors”/“metallochaperones”). (garza2023mitochondrialcopperin pages 4-6)

Metallochaperones and the IMS copper delivery pathway

A current framework for mitochondrial copper delivery places copper transfer into COX within the intermembrane space and mediated by cysteine-based metallochaperones that must maintain critical cysteines in a reduced state to bind and exchange copper. In this pathway, COX17 transfers copper to downstream assembly factors including SCO1 and SCO2 (for CuA-site assembly on COX2) and COX11 (for CuB-site assembly on COX1). (garza2023mitochondrialcopperin pages 4-6, garza2023mitochondrialcopperin pages 3-4)

3) Molecular function of SCO1 (what it does)

Primary function: COX2-specific copper metallochaperone for CuA insertion

Across recent reviews, SCO1 is described as a COX2-specific copper metallochaperone required for insertion of copper into the CuA site of COX2 during complex IV assembly. SCO1 is not described as catalyzing a small-molecule reaction; instead, its functional output is metal delivery/metallation and enabling maturation of complex IV. (garza2023mitochondrialcopperin pages 4-6, guaragnella2024morethanjust pages 4-5)

Cooperative action with SCO2 and model of CuA assembly

A recent synthesis emphasizes that in humans SCO1 and SCO2 can form a ternary complex with apo-COX2, with each SCO protein proposed to donate a single copper ion to build the binuclear CuA center. (guaragnella2024morethanjust pages 13-14)

4) Subcellular localization and topology (where it acts)

Human SCO1 is described as a mitochondrial inner membrane transmembrane protein with a short N-terminal matrix-facing tail and most of the polypeptide exposed to the IMS, consistent with its role in receiving copper from IMS-localized COX17 and delivering copper to the IMS-facing domain of COX2. (guaragnella2024morethanjust pages 13-14, guaragnella2024morethanjust pages 14-16)

5) Mechanism, domains/residues, and interaction partners

Structural/functional features (domain logic)

SCO1 is described as having a thioredoxin-like fold and a conserved CxxxC copper-binding motif, consistent with membership in the SCO-family of copper-handling proteins; copper binding by these metallochaperones depends on having key cysteines in a reduced state. (guaragnella2024morethanjust pages 13-14, garza2023mitochondrialcopperin pages 4-6)

Redox support by SCO2 and COA6 (keeping cysteines competent)

The IMS copper-handling network requires redox regulation: SCO2 and COA6 are described as acting as disulfide reductases/thiol-redox factors that maintain SCO1 (and/or COX2) in a copper-binding competent state. This connects SCO1 function to a broader redox-copper coupling in complex IV biogenesis. (garza2023mitochondrialcopperin pages 4-6, guaragnella2024morethanjust pages 24-25)

Interaction partners and pathway context

Recent reviews place SCO1 in a COX2/CuA module that includes:
- COX17 (upstream IMS copper donor),
- SCO2 (cofactor insertion/redox partner),
- COA6 (thiol reductase supporting CuA maturation),
- PET191/COA5 (associates with SCO1 before copper delivery),
- COX2 (direct copper acceptor for CuA),
with the broader pathway including other IMS assembly factors and copper-handling proteins. (guaragnella2024morethanjust pages 4-5, garza2023mitochondrialcopperin pages 4-6)

6) Recent developments and latest research (prioritizing 2023–2024)

6.1 2023: SCO1 in “mitochondrial copper disorders” framework

A 2023 Trends in Endocrinology & Metabolism review synthesizes SCO1 within the broader category of mitochondrial copper delivery disorders, emphasizing that defects in SCO1 disrupt COX2 CuA-site metallation and can produce fatal infantile disease with severe complex IV deficiency. (Publication date: Jan 2023; URL: https://doi.org/10.1016/j.tem.2022.11.001) (garza2023mitochondrialcopperin pages 4-6, garza2023mitochondrialcopperin pages 13-15)

6.2 2024: Updated COX assembly schematics and copper trafficking models

A 2024 review focused on COX deficiency/assembly provides updated schematics that explicitly group COX17, SCO1, and SCO2 as the CuA insertion machinery, and depicts mitochondrial copper trafficking to the IMS and then into the COX2 CuA site via SCO1. (Publication date: Mar 2024; URL: https://doi.org/10.3390/ijms25073814) (guaragnella2024morethanjust media 4fc2c616, guaragnella2024morethanjust media 0715036a)

6.3 2023–2024: Expanding SCO1 biology to systemic phenotypes in mammalian models

Two lines of 2023–2024 research broaden the functional implications of SCO1 loss beyond local complex IV assembly:

(i) Copper-dependent immunosuppression signaling axis (JCI 2023). In a hepatocyte-specific Sco1 loss model, mitochondrial dysfunction triggers secretion of α-fetoprotein (AFP) that requires copper and CCR5 to promote white blood cell death, connecting OXPHOS dysfunction and copper biology to systemic immune suppression. (Publication date: Jan 2023; URL: https://doi.org/10.1172/jci154684) (jett2023mitochondrialdysfunctionreactivates pages 1-2, jett2023mitochondrialdysfunctionreactivates pages 7-8)

(ii) Bone marrow progenitor defects and pan-lymphopenia (bioRxiv 2024). A 2024 preprint uses hepatocyte-specific Sco1 deletion to show pan-lymphopenia with substantial defects in B and T cell development, associated with reduced shared lymphoid progenitors (MPPLys and CLPs) and a broad shift in plasma cytokines and growth factors predicted to impair lymphopoiesis. (Publication date: Sep 2024; URL: https://doi.org/10.1101/2024.08.30.609186) (pioli2024ahepatocytespecificcytochrome pages 6-7, pioli2024ahepatocytespecificcytochrome pages 1-3)

7) Human disease relevance: phenotypes, variants, and functional readouts

7.1 Clinical phenotypes reported for SCO1 deficiency

Authoritative 2023–2024 syntheses describe severe neonatal/infantile presentations associated with SCO1 loss-of-function, including:
- hypertrophic cardiomyopathy / ventricular hypertrophy,
- hepatic failure / hepatomegaly,
- encephalopathy / brain atrophy,
- metabolic/lactic acidosis,
with fatal outcomes in early infancy in described cases. (garza2023mitochondrialcopperin pages 13-15, guaragnella2024morethanjust pages 13-14)

7.2 Reported pathogenic variants (examples in 2023–2024 syntheses)

Variants explicitly discussed in recent syntheses include V93X, G132S, P174L, and M294V, including compound heterozygous and homozygous cases associated with severe infantile phenotypes. (garza2023mitochondrialcopperin pages 13-15, guaragnella2024morethanjust pages 13-14)

7.3 Functional/biochemical evidence in patient materials (statistics/data)

The 2023 synthesis reports four infants with SCO1 loss-of-function summarized in that review, with all dying before 6 months, and with biochemical findings including decreased COX activity in liver and skeletal muscle and reduced COX-containing supercomplexes in skeletal muscle. (garza2023mitochondrialcopperin pages 13-15)

7.4 Variant interpretation using yeast functional modeling

Yeast-based modeling is highlighted as a practical approach to interpret pathogenicity and mechanism. For example, the P174L variant is described as adjacent to the copper-binding region and, in yeast modeling, it impairs copper transfer from COX17 despite normal copper binding, supporting a specific defect in copper handoff rather than complete loss of copper binding. (guaragnella2024morethanjust pages 13-14)

8) Current applications and real-world implementations

8.1 Clinical genetics and diagnostics (implementation)

SCO1 is a recognized nuclear gene in the diagnostic landscape for complex IV deficiency and mitochondrial disease with cardio-hepatic-neurologic involvement. The practical implementation is primarily through genomic sequencing panels/exome/genome followed by functional validation (e.g., enzymology of COX activity, assembly/supercomplex analysis, and model-organism functional tests). The 2023 and 2024 reviews explicitly position SCO1 among established COX assembly factors and mitochondrial copper delivery genes used to interpret severe infantile mitochondrial disorders. (garza2023mitochondrialcopperin pages 13-15, guaragnella2024morethanjust pages 24-25)

8.2 Translational model: gene restoration rescue in vivo

In a hepatocyte-specific Sco1 loss model, adenoviral restoration of SCO1 in liver is reported to rescue hepatic copper/CTR1-related parameters and to normalize systemic immune phenotypes (WBC counts and splenic/thymic atrophy), supporting proof-of-concept that tissue-targeted restoration of a COX assembly factor can reverse systemic consequences of mitochondrial dysfunction. (jett2023mitochondrialdysfunctionreactivates pages 2-3, jett2023mitochondrialdysfunctionreactivates pages 1-2)

9) Quantitative highlights (recent studies)

9.1 JCI 2023 (Sco1hep model; immune/metabolic outcomes)

  • Sco1hep mice: median life expectancy ~70 days. (jett2023mitochondrialdysfunctionreactivates pages 1-2)
  • Leukopenia evident by postnatal day 27; thymus and spleen show disproportionate atrophy by later timepoints. (jett2023mitochondrialdysfunctionreactivates pages 2-3)
  • PBMC phenotypes include increased activation/death markers (CD44, P = 0.017; annexin V, P = 0.003). (jett2023mitochondrialdysfunctionreactivates pages 7-8)

9.2 bioRxiv 2024 (plasma proteomics and immune development)

  • Plasma proteomics (array-based) identified 23 proteins increased and 133 decreased in Sco1 plasma under that analysis framework, including increases in inflammatory mediators and decreases in growth/hematopoietic factors (e.g., IGF-1, IL-7, CXCL12). (pioli2024ahepatocytespecificcytochrome pages 6-7)

10) Expert synthesis / interpretive analysis (authoritative sources)

Mechanistic consensus

Recent reviews converge on a mechanistic consensus that SCO1 is a core CuA-site metallochaperone operating at the IMS face of the inner membrane, receiving copper from COX17 and cooperating with SCO2/COA6-driven redox processes to enable copper insertion into COX2 and thus complex IV maturation. (garza2023mitochondrialcopperin pages 4-6, guaragnella2024morethanjust pages 13-14)

Systems-level interpretation

Recent primary research extends SCO1 significance from a “local” assembly factor to a driver of systemic copper-linked signaling when complex IV fails in specific tissues (notably liver), including copper-dependent AFP signaling leading to leukocyte toxicity and immune suppression, and circulating factor changes that impair lymphopoiesis. This systems-level view suggests that SCO1-related disease may include clinically relevant immune phenotypes in addition to classic bioenergetic failure. (jett2023mitochondrialdysfunctionreactivates pages 1-2, pioli2024ahepatocytespecificcytochrome pages 6-7)

Evidence map table

Category Key points Best supporting citations (pqac IDs) and source (paper, year, URL)
Localization/Topology Human SCO1 matches UniProt O75880 as a mitochondrial cytochrome c oxidase assembly factor in the SCO1/2 family. It is an inner mitochondrial membrane protein with a short N-terminal matrix tail and most of the polypeptide exposed to the intermembrane space, positioning its functional domain near COX2 CuA-site assembly. (guaragnella2024morethanjust pages 13-14, guaragnella2024morethanjust pages 14-16) Guaragnella et al., 2024, Int J Mol Sci, https://doi.org/10.3390/ijms25073814
Molecular function SCO1 is the COX2-specific copper metallochaperone for cytochrome c oxidase/complex IV biogenesis. Current understanding is that it inserts copper into the CuA site of COX2 rather than catalyzing a classic enzyme reaction; its role is metallation/assembly, with redox competence of cysteines required for function. (garza2023mitochondrialcopperin pages 4-6, garza2023mitochondrialcopperin pages 3-4, guaragnella2024morethanjust pages 4-5) Garza et al., 2023, Trends Endocrinol Metab, https://doi.org/10.1016/j.tem.2022.11.001; Guaragnella et al., 2024, Int J Mol Sci, https://doi.org/10.3390/ijms25073814
Copper delivery pathway In the mitochondrial copper delivery pathway, COX17 transfers copper in the intermembrane space to SCO1, SCO2, and COX11. SCO1 and SCO2 then cooperate in CuA-site assembly on apo-COX2; one recent model describes a ternary SCO1–SCO2–apoCOX2 complex in which each SCO protein donates one copper ion. PET191/COA5 associates with SCO1 prior to copper delivery. (guaragnella2024morethanjust pages 13-14, garza2023mitochondrialcopperin pages 4-6, guaragnella2024morethanjust pages 4-5, guaragnella2024morethanjust media 4fc2c616, guaragnella2024morethanjust media 0715036a) Guaragnella et al., 2024, Int J Mol Sci, https://doi.org/10.3390/ijms25073814; Garza et al., 2023, Trends Endocrinol Metab, https://doi.org/10.1016/j.tem.2022.11.001
Key residues/domains SCO1 has a thioredoxin-like fold and a copper-binding CxxxC motif characteristic of SCO-family proteins; available context states that cysteine-based copper binding requires the cysteines to remain reduced. The P174L pathogenic variant lies adjacent to the copper-binding region and impairs copper transfer from COX17 despite preserved copper binding in yeast-based modeling. (guaragnella2024morethanjust pages 13-14, garza2023mitochondrialcopperin pages 4-6, garza2023mitochondrialcopperin pages 3-4) Guaragnella et al., 2024, Int J Mol Sci, https://doi.org/10.3390/ijms25073814; Garza et al., 2023, Trends Endocrinol Metab, https://doi.org/10.1016/j.tem.2022.11.001
Interaction partners/complexes Key pathway partners include COX17, SCO2, COX2, COA6, COX11, and PET191/COA5. COA6 and SCO2 are described as disulfide reductases/thiol-redox factors that maintain SCO1 and/or COX2 in a copper-binding competent state; SCO1 functions within larger complex IV assembly modules and copper-trafficking assemblies. (guaragnella2024morethanjust pages 13-14, garza2023mitochondrialcopperin pages 4-6, guaragnella2024morethanjust pages 4-5) Guaragnella et al., 2024, Int J Mol Sci, https://doi.org/10.3390/ijms25073814; Garza et al., 2023, Trends Endocrinol Metab, https://doi.org/10.1016/j.tem.2022.11.001
Disease/phenotypes Human SCO1 deficiency causes severe neonatal/infantile mitochondrial disease with isolated or predominant complex IV deficiency. Reported phenotypes include neonatal hepatic failure, lactic acidosis, hypertrophic cardiomyopathy/ventricular hypertrophy, hepatomegaly, encephalopathy/brain atrophy, and fatal infantile cardio-hepatic-neurologic disease. Variants reported in context include V93X, G132S, P174L, and M294V. (guaragnella2024morethanjust pages 13-14, guaragnella2024morethanjust pages 24-25, garza2023mitochondrialcopperin pages 13-15) Guaragnella et al., 2024, Int J Mol Sci, https://doi.org/10.3390/ijms25073814; Garza et al., 2023, Trends Endocrinol Metab, https://doi.org/10.1016/j.tem.2022.11.001
Model organism evidence Yeast studies provide much of the mechanistic evidence: Sco1 is a Cu(I)-binding mitochondrial copper protein required for COX biogenesis and CuA-site assembly on Cox2. Yeast modeling of human variants supports pathogenic interpretation, including evidence that P174L disrupts copper transfer and that SCO2 can partially complement some SCO1 defects, indicating partial functional overlap but nonredundancy. (guaragnella2024morethanjust pages 13-14, guaragnella2024morethanjust pages 24-25, guaragnella2024morethanjust pages 14-16, guaragnella2024morethanjust pages 21-22) Guaragnella et al., 2024, Int J Mol Sci, https://doi.org/10.3390/ijms25073814
Quantitative data/stats Human case synthesis in the 2023 review notes 4 reported infants with SCO1 loss-of-function, all dying before 6 months, with decreased COX activity in liver and skeletal muscle and reduced COX-containing supercomplexes in skeletal muscle. In hepatocyte-specific Sco1 mouse models, median life expectancy is ~70 days; leukopenia is evident by postnatal day 27; thymus/spleen wet weights are reduced by P37 and P47; PBMC activation/death markers increase (CD44 P=0.017, annexin V P=0.003); plasma proteomics found 23 proteins increased and 133 decreased. (garza2023mitochondrialcopperin pages 13-15, jett2023mitochondrialdysfunctionreactivates pages 2-3, pioli2024ahepatocytespecificcytochrome pages 6-7, jett2023mitochondrialdysfunctionreactivates pages 1-2, jett2023mitochondrialdysfunctionreactivates pages 7-8) Garza et al., 2023, Trends Endocrinol Metab, https://doi.org/10.1016/j.tem.2022.11.001; Jett et al., 2023, J Clin Invest, https://doi.org/10.1172/jci154684; Pioli et al., 2024, bioRxiv, https://doi.org/10.1101/2024.08.30.609186
Recent developments 2023-2024 Recent literature emphasizes SCO1 as part of a broader mitochondrial copper-signaling network, not just a local assembly factor. 2023-2024 work links hepatocyte-specific Sco1 loss to hepatic copper deficiency, elevated circulating copper/ceruloplasmin, AFP-dependent copper-requiring immunosuppression, and bone-marrow lymphoid progenitor defects, expanding SCO1 biology from complex IV metallation to systemic pathophysiology in mitochondrial disease models. Review/schematic updates in 2024 also refine the assembly sequence involving COX17, SCO1, SCO2, COA6, PET191, and COX2 CuA insertion. (jett2023mitochondrialdysfunctionreactivates pages 2-3, pioli2024ahepatocytespecificcytochrome pages 6-7, pioli2024ahepatocytespecificcytochrome pages 1-3, jett2023mitochondrialdysfunctionreactivates pages 7-8, guaragnella2024morethanjust media 4fc2c616, guaragnella2024morethanjust media 0715036a) Jett et al., 2023, J Clin Invest, https://doi.org/10.1172/jci154684; Pioli et al., 2024, bioRxiv, https://doi.org/10.1101/2024.08.30.609186; Guaragnella et al., 2024, Int J Mol Sci, https://doi.org/10.3390/ijms25073814

Table: This table summarizes the current functional annotation of human SCO1 (UniProt O75880), including molecular role, localization, pathway context, disease relevance, and recent 2023-2024 developments. It is useful as a compact evidence map linking mechanistic and clinical findings to specific sources.

Key schematic evidence (visual)

A 2024 COX assembly review provides schematics of (i) the COX assembly modules showing CuA insertion factors (COX17/SCO1/SCO2) and (ii) mitochondrial copper trafficking culminating in SCO1-mediated delivery to the COX2 CuA site. (guaragnella2024morethanjust media 4fc2c616, guaragnella2024morethanjust media 0715036a)

References (URLs and publication dates as available in retrieved sources)

  • Garza NM, Swaminathan AB, Maremanda KP, et al. Mitochondrial copper in human genetic disorders. Trends in Endocrinology & Metabolism. Jan 2023. https://doi.org/10.1016/j.tem.2022.11.001 (garza2023mitochondrialcopperin pages 13-15, garza2023mitochondrialcopperin pages 4-6)
  • Guaragnella N, Cervelli T, Sampaio-Marques B, et al. More than Just Bread and Wine: Using Yeast to Understand Inherited Cytochrome Oxidase Deficiencies in Humans. International Journal of Molecular Sciences. Mar 2024. https://doi.org/10.3390/ijms25073814 (guaragnella2024morethanjust pages 13-14, guaragnella2024morethanjust media 4fc2c616, guaragnella2024morethanjust media 0715036a)
  • Jett KA, Baker ZN, Hossain A, et al. Mitochondrial dysfunction reactivates α-fetoprotein expression that drives copper-dependent immunosuppression in mitochondrial disease models. Journal of Clinical Investigation. Jan 2023. https://doi.org/10.1172/jci154684 (jett2023mitochondrialdysfunctionreactivates pages 1-2, jett2023mitochondrialdysfunctionreactivates pages 7-8)
  • Pioli KAT, Ghosh S, Boulet A, Leary SC, Pioli PD. A hepatocyte-specific cytochrome c oxidase deficiency in mice leads to a lymphopenia owing to deficiencies in bone marrow progenitors. bioRxiv. Sep 2024. https://doi.org/10.1101/2024.08.30.609186 (pioli2024ahepatocytespecificcytochrome pages 6-7, pioli2024ahepatocytespecificcytochrome pages 1-3)

References

  1. (guaragnella2024morethanjust pages 13-14): Nicoletta Guaragnella, T. Cervelli, Bel é m Sampaio-Marques, Chenelle A. Caron-Godon, Emma Collington, Jessica L. Wolf, Genna Coletta, and D. M. Glerum. More than just bread and wine: using yeast to understand inherited cytochrome oxidase deficiencies in humans. International Journal of Molecular Sciences, 25:3814, Mar 2024. URL: https://doi.org/10.3390/ijms25073814, doi:10.3390/ijms25073814. This article has 5 citations.

  2. (garza2023mitochondrialcopperin pages 4-6): Natalie M. Garza, Abhinav B. Swaminathan, Krishna P. Maremanda, Mohammad Zulkifli, and Vishal M. Gohil. Mitochondrial copper in human genetic disorders. Trends in Endocrinology & Metabolism, 34:21-33, Jan 2023. URL: https://doi.org/10.1016/j.tem.2022.11.001, doi:10.1016/j.tem.2022.11.001. This article has 126 citations and is from a domain leading peer-reviewed journal.

  3. (garza2023mitochondrialcopperin pages 3-4): Natalie M. Garza, Abhinav B. Swaminathan, Krishna P. Maremanda, Mohammad Zulkifli, and Vishal M. Gohil. Mitochondrial copper in human genetic disorders. Trends in Endocrinology & Metabolism, 34:21-33, Jan 2023. URL: https://doi.org/10.1016/j.tem.2022.11.001, doi:10.1016/j.tem.2022.11.001. This article has 126 citations and is from a domain leading peer-reviewed journal.

  4. (guaragnella2024morethanjust pages 4-5): Nicoletta Guaragnella, T. Cervelli, Bel é m Sampaio-Marques, Chenelle A. Caron-Godon, Emma Collington, Jessica L. Wolf, Genna Coletta, and D. M. Glerum. More than just bread and wine: using yeast to understand inherited cytochrome oxidase deficiencies in humans. International Journal of Molecular Sciences, 25:3814, Mar 2024. URL: https://doi.org/10.3390/ijms25073814, doi:10.3390/ijms25073814. This article has 5 citations.

  5. (guaragnella2024morethanjust pages 14-16): Nicoletta Guaragnella, T. Cervelli, Bel é m Sampaio-Marques, Chenelle A. Caron-Godon, Emma Collington, Jessica L. Wolf, Genna Coletta, and D. M. Glerum. More than just bread and wine: using yeast to understand inherited cytochrome oxidase deficiencies in humans. International Journal of Molecular Sciences, 25:3814, Mar 2024. URL: https://doi.org/10.3390/ijms25073814, doi:10.3390/ijms25073814. This article has 5 citations.

  6. (guaragnella2024morethanjust pages 24-25): Nicoletta Guaragnella, T. Cervelli, Bel é m Sampaio-Marques, Chenelle A. Caron-Godon, Emma Collington, Jessica L. Wolf, Genna Coletta, and D. M. Glerum. More than just bread and wine: using yeast to understand inherited cytochrome oxidase deficiencies in humans. International Journal of Molecular Sciences, 25:3814, Mar 2024. URL: https://doi.org/10.3390/ijms25073814, doi:10.3390/ijms25073814. This article has 5 citations.

  7. (garza2023mitochondrialcopperin pages 13-15): Natalie M. Garza, Abhinav B. Swaminathan, Krishna P. Maremanda, Mohammad Zulkifli, and Vishal M. Gohil. Mitochondrial copper in human genetic disorders. Trends in Endocrinology & Metabolism, 34:21-33, Jan 2023. URL: https://doi.org/10.1016/j.tem.2022.11.001, doi:10.1016/j.tem.2022.11.001. This article has 126 citations and is from a domain leading peer-reviewed journal.

  8. (guaragnella2024morethanjust media 4fc2c616): Nicoletta Guaragnella, T. Cervelli, Bel é m Sampaio-Marques, Chenelle A. Caron-Godon, Emma Collington, Jessica L. Wolf, Genna Coletta, and D. M. Glerum. More than just bread and wine: using yeast to understand inherited cytochrome oxidase deficiencies in humans. International Journal of Molecular Sciences, 25:3814, Mar 2024. URL: https://doi.org/10.3390/ijms25073814, doi:10.3390/ijms25073814. This article has 5 citations.

  9. (guaragnella2024morethanjust media 0715036a): Nicoletta Guaragnella, T. Cervelli, Bel é m Sampaio-Marques, Chenelle A. Caron-Godon, Emma Collington, Jessica L. Wolf, Genna Coletta, and D. M. Glerum. More than just bread and wine: using yeast to understand inherited cytochrome oxidase deficiencies in humans. International Journal of Molecular Sciences, 25:3814, Mar 2024. URL: https://doi.org/10.3390/ijms25073814, doi:10.3390/ijms25073814. This article has 5 citations.

  10. (jett2023mitochondrialdysfunctionreactivates pages 1-2): Kimberly A. Jett, Zakery N. Baker, Amzad Hossain, Aren Boulet, Paul A. Cobine, Sagnika Ghosh, Philip Ng, Orhan Yilmaz, Kris Barreto, John DeCoteau, Karen Mochoruk, George N. Ioannou, Christopher Savard, Sai Yuan, Osama H.M.H. Abdalla, Christopher Lowden, Byung-Eun Kim, Hai-Ying Mary Cheng, Brendan J. Battersby, Vishal M. Gohil, and Scot C. Leary. Mitochondrial dysfunction reactivates α-fetoprotein expression that drives copper-dependent immunosuppression in mitochondrial disease models. Journal of Clinical Investigation, Jan 2023. URL: https://doi.org/10.1172/jci154684, doi:10.1172/jci154684. This article has 16 citations and is from a highest quality peer-reviewed journal.

  11. (jett2023mitochondrialdysfunctionreactivates pages 7-8): Kimberly A. Jett, Zakery N. Baker, Amzad Hossain, Aren Boulet, Paul A. Cobine, Sagnika Ghosh, Philip Ng, Orhan Yilmaz, Kris Barreto, John DeCoteau, Karen Mochoruk, George N. Ioannou, Christopher Savard, Sai Yuan, Osama H.M.H. Abdalla, Christopher Lowden, Byung-Eun Kim, Hai-Ying Mary Cheng, Brendan J. Battersby, Vishal M. Gohil, and Scot C. Leary. Mitochondrial dysfunction reactivates α-fetoprotein expression that drives copper-dependent immunosuppression in mitochondrial disease models. Journal of Clinical Investigation, Jan 2023. URL: https://doi.org/10.1172/jci154684, doi:10.1172/jci154684. This article has 16 citations and is from a highest quality peer-reviewed journal.

  12. (pioli2024ahepatocytespecificcytochrome pages 6-7): KimAnh T. Pioli, Sampurna Ghosh, Aren Boulet, Scot C. Leary, and Peter D. Pioli. A hepatocyte-specific cytochrome c oxidase deficiency in mice leads to a lymphopenia owing to deficiencies in bone marrow progenitors. bioRxiv, Sep 2024. URL: https://doi.org/10.1101/2024.08.30.609186, doi:10.1101/2024.08.30.609186. This article has 0 citations.

  13. (pioli2024ahepatocytespecificcytochrome pages 1-3): KimAnh T. Pioli, Sampurna Ghosh, Aren Boulet, Scot C. Leary, and Peter D. Pioli. A hepatocyte-specific cytochrome c oxidase deficiency in mice leads to a lymphopenia owing to deficiencies in bone marrow progenitors. bioRxiv, Sep 2024. URL: https://doi.org/10.1101/2024.08.30.609186, doi:10.1101/2024.08.30.609186. This article has 0 citations.

  14. (jett2023mitochondrialdysfunctionreactivates pages 2-3): Kimberly A. Jett, Zakery N. Baker, Amzad Hossain, Aren Boulet, Paul A. Cobine, Sagnika Ghosh, Philip Ng, Orhan Yilmaz, Kris Barreto, John DeCoteau, Karen Mochoruk, George N. Ioannou, Christopher Savard, Sai Yuan, Osama H.M.H. Abdalla, Christopher Lowden, Byung-Eun Kim, Hai-Ying Mary Cheng, Brendan J. Battersby, Vishal M. Gohil, and Scot C. Leary. Mitochondrial dysfunction reactivates α-fetoprotein expression that drives copper-dependent immunosuppression in mitochondrial disease models. Journal of Clinical Investigation, Jan 2023. URL: https://doi.org/10.1172/jci154684, doi:10.1172/jci154684. This article has 16 citations and is from a highest quality peer-reviewed journal.

  15. (guaragnella2024morethanjust pages 21-22): Nicoletta Guaragnella, T. Cervelli, Bel é m Sampaio-Marques, Chenelle A. Caron-Godon, Emma Collington, Jessica L. Wolf, Genna Coletta, and D. M. Glerum. More than just bread and wine: using yeast to understand inherited cytochrome oxidase deficiencies in humans. International Journal of Molecular Sciences, 25:3814, Mar 2024. URL: https://doi.org/10.3390/ijms25073814, doi:10.3390/ijms25073814. This article has 5 citations.

Artifacts

Citations

  1. garza2023mitochondrialcopperin pages 4-6
  2. guaragnella2024morethanjust pages 13-14
  3. garza2023mitochondrialcopperin pages 13-15
  4. jett2023mitochondrialdysfunctionreactivates pages 1-2
  5. jett2023mitochondrialdysfunctionreactivates pages 2-3
  6. jett2023mitochondrialdysfunctionreactivates pages 7-8
  7. pioli2024ahepatocytespecificcytochrome pages 6-7
  8. garza2023mitochondrialcopperin pages 3-4
  9. guaragnella2024morethanjust pages 4-5
  10. guaragnella2024morethanjust pages 14-16
  11. guaragnella2024morethanjust pages 24-25
  12. pioli2024ahepatocytespecificcytochrome pages 1-3
  13. guaragnella2024morethanjust pages 21-22
  14. https://doi.org/10.1016/j.tem.2022.11.001
  15. https://doi.org/10.3390/ijms25073814
  16. https://doi.org/10.1172/jci154684
  17. https://doi.org/10.1101/2024.08.30.609186
  18. https://doi.org/10.1016/j.tem.2022.11.001;
  19. https://doi.org/10.3390/ijms25073814;
  20. https://doi.org/10.1172/jci154684;
  21. https://doi.org/10.1101/2024.08.30.609186;
  22. https://doi.org/10.3390/ijms25073814,
  23. https://doi.org/10.1016/j.tem.2022.11.001,
  24. https://doi.org/10.1172/jci154684,
  25. https://doi.org/10.1101/2024.08.30.609186,

OpenScientist

(SCO1-hypotheses/core-function-1-go-0016531/openscientist.md)
SCO1 Core Function Hypothesis: Copper Chaperone Activity (GO:0016531) OpenScientist openscientist-autonomous 15 citations 2026-05-20T10:21:26.181325 citations file

SCO1 Core Function Hypothesis: Copper Chaperone Activity (GO:0016531)

Executive Judgment

Verdict: SUPPORTED — with a high-priority curation upgrade recommended.

Copper chaperone activity (GO:0016531) is well-supported as a core molecular function of human SCO1. The hypothesis that SCO1's primary role is copper handling within the COX2 maturation pathway — rather than mature Complex IV catalysis — is substantiated by converging structural, biochemical, genetic, and pathway-ordering evidence across multiple organisms and experimental systems. SCO1 binds Cu(I) through a conserved CxxxCP motif within a thioredoxin fold, physically associates with the cytochrome c oxidase (COX) complex, and is positioned as the direct copper donor to the CuA site of MT-CO2/COX2, downstream of SCO2 in a sequential relay pathway. Loss-of-function mutations in SCO1 consistently produce COX deficiency coupled with copper depletion phenotypes, reinforcing that its essential activity is copper delivery rather than a structural or catalytic role within the assembled holoenzyme.

The most important caveat is that the current GO annotation for this term relies solely on electronic annotation (IEA, InterPro-derived). Multiple primary research papers — particularly PMID: 15229189 and PMID: 19336478 — provide experimental evidence that would justify an upgrade to IMP (Inferred from Mutant Phenotype). This evidence-code upgrade is the single most actionable curation recommendation arising from this analysis. Additionally, the paralog SCO2 carries the same GO:0016531 annotation, but accumulating evidence indicates SCO2 functions primarily as a thiol-disulfide oxidoreductase for SCO1 rather than as a direct copper donor, suggesting its annotation should be re-evaluated.


Summary

SCO1 (Synthesis of Cytochrome c Oxidase 1) is a nuclear-encoded, mitochondrial inner membrane protein that functions as a copper metallochaperone essential for the biogenesis of cytochrome c oxidase (Complex IV). This report evaluates the hypothesis that copper chaperone activity (GO:0016531) represents a core molecular function of SCO1, as opposed to a secondary or context-dependent role.

Three independent lines of evidence converge on strong support for this assignment. First, structural evidence from NMR solution structures of Sco1 orthologs demonstrates a thioredoxin-like fold with a CxxxCP copper-binding motif that coordinates Cu(I) through conserved cysteine and histidine residues (PMID: 14604533). Second, genetic and functional evidence from human patient cells, mouse knockouts, and yeast complementation studies shows that SCO1 mutations specifically impair copper metallation of COX2 while leaving COX2 protein synthesis intact, distinguishing SCO1's copper delivery role from the upstream function of SCO2 in COX2 synthesis (PMID: 19336478; PMID: 15229189). Third, pathway-ordering evidence demonstrates that SCO2 acts as a thiol-disulfide oxidoreductase that modulates the redox state of SCO1's copper-binding cysteines, placing SCO1 as the terminal copper donor in a relay from COX17 → SCO2 → SCO1 → COX2 CuA site.

An additional dimension of SCO1 function — regulation of cellular copper homeostasis through maintenance of the high-affinity copper transporter CTR1 at the plasma membrane — has been documented in mouse models (PMID: 28973536). While this represents a biologically important activity, it is mechanistically downstream of and dependent upon SCO1's primary copper-handling role, and may warrant separate GO annotation rather than replacing the copper chaperone designation.


Key Findings

Finding 1: GO:0016531 Is Biologically Correct but Annotated Only as IEA

The current Gene Ontology annotation of copper chaperone activity (GO:0016531) to human SCO1 (UniProt O75880) is derived solely from electronic annotation (IEA) via InterPro domain predictions (GO_REF:0000002). No experimental molecular function annotation (IDA, IMP, IGI, etc.) exists for this term on SCO1 in major GO databases. However, the experimentally supported annotation GO:0033617 (mitochondrial respiratory chain complex IV assembly, IMP, PMID: 15229189) is present, confirming that experimental evidence for SCO1's role in copper-dependent COX assembly has been curated — but the molecular function term itself has not been upgraded from its electronic origin.

This is a significant curation gap. The biological process annotation (IMP) implicitly depends on SCO1's copper chaperone activity, yet the molecular function annotation lacks experimental backing. Upgrading GO:0016531 to IMP status, citing PMID: 15229189 and PMID: 19336478, would bring the annotation in line with the strength of available evidence. The key evidence is that loss of SCO1 function specifically abolishes copper metallation of COX2 while leaving protein synthesis intact — a mutant phenotype directly implicating copper chaperone activity as the molecular function.

Finding 2: SCO1 Binds Cu(I) via Conserved CxxxCP Motif with Thioredoxin Fold

Structural characterization of Sco1 from Bacillus subtilis by NMR (PMID: 14604533) revealed a thioredoxin-like fold with copper(I) binding mediated by the CxxxCP motif and His135. The study demonstrated that "in vitro Sco1 binds copper(I) through a CXXXCP motif and possibly His 135 and copper(II) in two different species, thus suggesting that copper(II) is adventitious more than physiological." This establishes a direct biochemical basis for copper chaperone activity: the protein specifically binds the physiologically relevant Cu(I) species through defined structural elements.

Human SCO1 retains this conserved CxxxC motif with confirmed functionality (PMID: 19336478). The redox state of these cysteines is critical for function — SCO1 must be in the reduced (thiol) form to bind copper, and the oxidized (disulfide) form is copper-free. This redox-dependent copper binding is a hallmark of metallochaperone activity and distinguishes SCO1 from proteins that merely bind copper as a structural cofactor. Multiple studies confirm that SCO1 exists in both oxidized (disulfide) and reduced (thiol) copper-binding states, with the interconversion regulated by SCO2 and COA6.

Finding 3: SCO2 Acts as Thiol-Disulfide Oxidoreductase for SCO1, Not as Direct Copper Donor

A key finding from PMID: 19336478 established that "SCO2 acts upstream of SCO1, and that it is indispensable for CO II synthesis" while SCO1 "is required for COII copper metallation." This pathway ordering is critical for GO curation because it demonstrates that SCO1 and SCO2 have non-overlapping, mechanistically distinct roles despite both being annotated with GO:0016531 (copper chaperone activity).

SCO2's primary function appears to be oxidizing the copper-coordinating cysteines in SCO1, functioning as a thiol-disulfide oxidoreductase. This is further supported by recent work showing that the LRRK2 Parkinson's disease kinase regulates the redox status of SCO1 and COX11, with pathogenic LRRK2 G2019S increasing the proportion of reduced (Cu-deficient) forms (PMID: 41621246). The cooperative but non-overlapping relationship was originally established by PMID: 15229189, which showed that "the human SCO proteins have non-overlapping, cooperative functions in mitochondrial copper delivery."

This evidence suggests that GO:0016531 is more precisely applicable to SCO1 than to SCO2. SCO2 may be better annotated with a thiol-disulfide oxidoreductase molecular function term (e.g., GO:0015036, disulfide oxidoreductase activity) rather than copper chaperone activity. This distinction is not merely semantic — it reflects fundamentally different biochemical activities within the copper relay pathway.


Mechanistic Model and Interpretation

The Copper Relay Pathway to COX2 CuA

SCO1 operates within a well-characterized copper relay pathway in the mitochondrial intermembrane space (IMS). The pathway delivers copper from the cytoplasm to the CuA site of COX2 during Complex IV assembly:

Cytoplasm / IMS                     Inner Membrane
────────────────────────────────────────────────────

  CTR1  COX17 ──→ COX11 ───────→ COX2 CuB site
  (Cu import)     └──→ SCO2 ──→ SCO1 ──→ COX2 CuA site
                           (Cu(I)            donor)         └──redox──→──┘
      (thiol-disulfide
       oxidoreductase)
                      COA6
      (thiol-reductase
       for SCO1/SCO2)

Key mechanistic points:

  1. COX17 shuttles Cu(I) from the cytoplasm to the IMS, donating it to both the SCO and COX11 branches.
  2. SCO2 does not directly transfer copper to COX2. Instead, it acts as a thiol-disulfide oxidoreductase, oxidizing SCO1's copper-coordinating cysteines to the disulfide form. This redox cycling is required for proper COX2 synthesis (PMID: 19336478).
  3. SCO1 is the terminal copper metallochaperone: it binds Cu(I) through its reduced CxxxC thiols and directly delivers copper to the nascent COX2 CuA site.
  4. COA6 acts as a thiol-reductase for SCO1 and SCO2, maintaining the proper redox states within the complex (PMID: 32061935).
  5. COX16 cooperates with this pathway to promote COX2 metallation and assembly (PMID: 29381136).
  6. FKBP4 controls assembly of the COA6/SCO1/SCO2 complex in the IMS (PMID: 35981890).

Separating Direct Activity from Downstream Effects

Level Description GO Category
Direct MF Cu(I) binding and transfer to COX2 CuA site GO:0016531 ✓
Direct BP COX2 metallation / Complex IV assembly GO:0033617 ✓
Direct CC Mitochondrial inner membrane / IMS GO:0005743 ✓
Secondary activity CTR1 regulation at plasma membrane GO:0006878 (consider adding)
Pathway consequence Functional respiratory chain Not SCO1 MF
Disease phenotype Cardiomyopathy, hepatopathy, encephalopathy Not SCO1 MF

SCO1's Dual Role: Copper Chaperone + Copper Homeostasis Regulator

A notable finding is that SCO1 has a function beyond COX assembly. PMID: 28973536 demonstrated that "the reduction in copper content of Sco1stm/stm cardiomyocytes was due to the mislocalisation of CTR1, the high affinity transporter that imports copper into the cell." This CTR1-regulatory function is tissue-specific — in heart, SCO1 loss causes CTR1 mislocalization to the cytosol, while in liver, it causes near-complete CTR1 absence. This suggests SCO1 serves as a mitochondrial copper sensor that signals to maintain copper import machinery at the cell surface.

However, this homeostatic role likely depends on SCO1's copper-binding capacity (the same CxxxC motif involved in chaperone activity), making copper chaperone activity the more fundamental molecular function. The homeostasis role may represent a regulatory output of SCO1's copper-binding state rather than a mechanistically independent activity.


Evidence Matrix

# Citation Evidence Type Direction Claim Tested Key Finding Context Confidence
1 PMID: 15229189 Genetic complementation / mutant phenotype Supports SCO1 is essential for copper delivery to COX SCO1 and SCO2 have non-overlapping, cooperative functions in mitochondrial copper delivery Human patient fibroblasts High — direct genetic evidence in human cells
2 PMID: 19336478 Mutant phenotype / biochemical Supports + Qualifies SCO1 is the direct copper donor to COX2 SCO2 acts upstream of SCO1 as thiol-disulfide oxidoreductase; SCO1 required for COII copper metallation (not synthesis) Human patient cell lines, pulse-labeling High — establishes pathway order
3 PMID: 14604533 Structural (NMR) / direct assay Supports SCO1 binds copper ions Solution structure shows Cu(I) binding via CxxxCP motif and His135; thioredoxin fold B. subtilis Sco1 (bacterial ortholog) Moderate — bacterial ortholog, but motif conserved in human
4 PMID: 40679281 Mutant phenotype (knockin mice) Supports SCO1 mutations cause COX and copper deficiency Multiple pathogenic SCO1 variants cause tissue-specific COX deficiency and mitochondrial copper depletion; heart most susceptible Mouse knockin models of human SCO1 variants High — in vivo mammalian model
5 PMID: 28973536 Mutant phenotype (conditional KO) Supports + Qualifies SCO1 regulates copper homeostasis beyond COX SCO1 deletion causes CTR1 mislocalization, reducing cellular copper import; distinct from COX assembly role Mouse heart-specific Sco1 KO High — qualifies that SCO1 has functions beyond COX copper chaperoning
6 PMID: 32061935 Biochemical / interaction Supports COA6/SCO1/SCO2 form a functional complex COA6 acts as thiol-reductase for SCO1 and SCO2, facilitating copper metallochaperone function Human cells (HEK293T) High — defines molecular complex
7 PMID: 19295170 Mutant phenotype / biochemical Supports SCO1 is required for COX2 maturation G132S SCO1 mutation destabilizes protein; COX activity reduced to 10–20% of control; Cox2 subcomplexes accumulate; Sco1 physically associates with COX complex Human patient muscle tissue High — direct patient tissue evidence
8 PMID: 41621246 Biochemical / genetic Supports SCO1 redox state governs copper chaperone function LRRK2 G2019S increases reduced (Cu-deficient) SCO1, impairing COX assembly Neuronal cells, mouse in vivo Moderate — disease-model context
9 PMID: 20388558 Genetic / evolutionary Supports SCO copper chaperone function is conserved Drosophila has single SCO gene (scox); null is larval lethal; orthologs in 39 eukaryotic species D. melanogaster, evolutionary Moderate — conservation supports functional annotation
10 PMID: 35981890 Interaction / functional Supports SCO1 participates in copper metallation complex FKBP4 controls assembly of COA6/SCO1/SCO2 complex; disruption impairs COX biogenesis Human colon cancer cells Moderate — cancer cell context
11 PMID: 29381136 Biochemical / interaction Qualifies COX16 also participates in COX2 metallation COX16 promotes COX2 metallation and assembly during Complex IV biogenesis Human cells Moderate — parallel pathway factor
12 PMID: 20136502 Review / mechanistic synthesis Supports Redox regulation integral to SCO1 metallochaperone function Cysteine redox changes modulate SCO1 copper binding and delivery; links to copper homeostasis signaling Review (yeast + human data) Review-level; comprehensive
13 PMID: 15113935 Review Supports SCO1 is copper chaperone in canonical pathway Cox17 delivers copper via Cox11, Sco1, and Sco2 to COX Review Review-level; establishes context
14 PMID: 25792727 Mutant phenotype Supports SCO deficiency causes COX deficiency Heart-specific scox knockdown reduces COX activity, causes metabolic switch to glycolysis, dilated cardiomyopathy Drosophila heart Moderate — invertebrate model
15 PMID: 21821119 Mutant phenotype Qualifies Sco1 has roles in peroxide metabolism sco1 null shows H₂O₂ sensitivity; suppressed by SCO2 or COX11 overexpression; Sco1p and Cox11p play overlapping roles in peroxide metabolism Yeast Moderate — additional function in yeast

GO Curation Implications

Current Annotation State

GO Term Evidence Code Reference
GO:0016531 (copper chaperone activity, MF) IEA InterPro (GO_REF:0000002)
GO:0005507 (copper ion binding, MF) IEA InterPro
GO:0033617 (mito. complex IV assembly, BP) IMP PMID:15229189
GO:0005743 (mito. inner membrane, CC) IDA PMID:15229189

1. Upgrade GO:0016531 evidence code from IEA to IMP (HIGH PRIORITY)

The literature supports this annotation with experimental evidence:
- IMP candidate reference: PMID: 15229189 — Mutant SCO1 patient cells show impaired copper delivery to COX; copper metallochaperoning function inferred from mutant phenotype. Snippet: "Our results demonstrate that the human SCO proteins have non-overlapping, cooperative functions in mitochondrial copper delivery."
- IMP candidate reference: PMID: 19336478 — Pathway ordering shows SCO1 required for COII copper metallation, not synthesis. Snippet: "These results indicate that SCO2 acts upstream of SCO1, and that it is indispensable for CO II synthesis."

2. Retain GO:0016531 as core MF — term is appropriately specific.

The GO:0016531 definition ("Directly binding to and delivering copper ions to a target protein") accurately describes SCO1's function. The term is neither too broad (it specifies copper chaperoning, not generic metal binding) nor too narrow (SCO1 does deliver copper to a specific target). No more specific child term exists that would better capture SCO1's activity.

3. Re-evaluate GO:0016531 for SCO2 (MEDIUM PRIORITY)

SCO2 likely also carries GO:0016531 via IEA. Evidence from PMID: 19336478 demonstrates SCO2 functions as a thiol-disulfide oxidoreductase for SCO1, not as a direct copper donor. Consider replacing or supplementing with GO:0015036 (disulfide oxidoreductase activity) or a more specific oxidoreductase term.

4. Consider additional BP annotation for copper homeostasis (LOW PRIORITY)

Mouse data (PMID: 28973536) strongly support SCO1's role in cellular copper ion homeostasis (GO:0006878) via CTR1 regulation at the plasma membrane. Direct human evidence is currently annotated "By similarity" only.

5. Retain existing BP and CC annotations — confirmed as appropriate.

GO:0033617 (mitochondrial respiratory chain complex IV assembly, IMP) and GO:0005743 (mitochondrial inner membrane, IDA) are correctly annotated with appropriate evidence.

GO Decision Summary Table

GO Term Current Evidence Recommendation Priority
GO:0016531 (copper chaperone activity) IEA Upgrade to IMP (PMID:15229189, PMID:19336478) HIGH
GO:0005507 (copper ion binding) IEA Consider upgrade to ISS (PMID:14604533) Medium
GO:0033617 (complex IV assembly) IMP Retain — well-annotated None
GO:0005743 (mito. inner membrane) IDA Retain — well-annotated None
GO:0006878 (copper homeostasis) IEA Consider ISS from mouse data (PMID:28973536) Low
SCO2: GO:0016531 IEA Re-evaluate — consider oxidoreductase MF Medium

Conflicts and Alternatives

1. SCO2 Paralog Confusion Risk

Both SCO1 and SCO2 are annotated with GO:0016531 via IEA/InterPro. However, PMID: 19336478 demonstrates they have fundamentally different molecular activities: SCO1 is the direct copper metallochaperone (binds and delivers Cu to COX2), while SCO2 is a thiol-disulfide oxidoreductase (oxidizes SCO1's copper-coordinating cysteines). This represents a potential paralog over-annotation issue where pathway membership has been conflated with molecular function identity. GO:0016531 is more accurately applied to SCO1 than SCO2.

2. Bacterial vs. Human Structural Evidence Gap

The strongest direct biochemical evidence for copper binding (NMR structure, PMID: 14604533) comes from B. subtilis Sco1. While the CxxxCP motif is conserved and human mutagenesis data confirm the cysteines are essential (PMID: 19336478), direct in vitro demonstration of copper transfer from purified human SCO1 to purified human COX2 has not been published. This means the human GO annotation at IDA level would require ISS (Inferred from Sequence/Structural Similarity) qualification if based on the structural data.

3. COA6 Complex Complication

COA6 acts as a thiol-reductase for both SCO1 and SCO2 (PMID: 32061935). Some literature describes SCO1's function as part of a "COA6/SCO1/SCO2 complex" rather than as an independent chaperone. However, this does not contradict GO:0016531 — it contextualizes the copper delivery as requiring accessory factors, analogous to how many enzymes require cofactors while retaining their individual MF annotations.

4. Assembly Factor vs. Chaperone Framing

Some references (e.g., UniProt recommended name: "Cytochrome c oxidase assembly factor SCO1") frame SCO1 primarily as a COX assembly factor rather than a copper chaperone. Both are correct at different levels of specificity — GO:0016531 captures the molecular function, while COX assembly (GO:0033617) captures the biological process. The MF and BP annotations are complementary, not competing.

5. Additional Roles in Peroxide Metabolism

In yeast, sco1 null strains show hydrogen peroxide sensitivity (PMID: 21821119). This may reflect disrupted copper-dependent antioxidant pathways rather than a direct SCO1 enzymatic activity. It does not challenge the copper chaperone designation but suggests additional context-dependent functional consequences.


Knowledge Gaps

Gap What Was Checked Why It Matters Resolving Evidence
No in vitro copper transfer assay with purified human SCO1 → COX2 PubMed literature search Would provide IDA-level evidence for GO:0016531 in human Purified human SCO1 + COX2 copper transfer assay with spectroscopic detection
No human SCO1 Cu-bound structure PubMed search for human SCO1 crystal/NMR structures IDA annotation ideally references direct Cu binding by human protein Crystal/cryo-EM structure of human SCO1 with bound Cu(I)
Copper homeostasis mechanism in human cells UniProt states "By similarity"; PMID:28973536 is mouse data Determines whether copper homeostasis function should be annotated for human SCO1 with experimental evidence Human cell line studies of CTR1 localization upon SCO1 knockdown
Stoichiometry and kinetics of copper transfer in the COA6/SCO1/SCO2 complex PMID:32061935 identifies complex but details incomplete Affects whether SCO1 "delivers" copper independently or only within the complex Crosslinking-MS, cryo-EM of the complex with copper
Whether SCO1 transfers copper to any target other than COX2 No evidence found for alternative targets Would broaden or restrict GO:0016531 annotation context Interactome studies with copper-loaded SCO1
Tissue-specific variation in SCO1 function PMID:40679281 shows heart > brain > liver susceptibility May affect tissue-specific curation context Tissue-specific proteomics and copper measurements

Discriminating Tests

  1. In vitro copper transfer reconstitution assay: Purify human SCO1 and COX2 (or a COX2 CuA-site peptide); load SCO1 with Cu(I); measure copper transfer spectroscopically (UV-Vis, EXAFS, or ICP-MS). This would provide definitive IDA evidence for GO:0016531 and resolve the bacterial-vs-human structural gap.

  2. Copper-binding-dead SCO1 mutant complementation: Express SCO1 with CxxxC→AxxxA mutations in SCO1-deficient patient cells. If COX activity is not rescued (expected), this confirms copper binding is essential for the chaperone function, not just the protein scaffold.

  3. Separation-of-function mutants: Engineer SCO1 mutants that retain copper binding but lose CTR1 regulation (or vice versa) to determine whether these are mechanistically separable functions requiring separate GO annotations.

  4. SCO1 vs SCO2 copper occupancy measurement: Use XAS or native mass spectrometry to compare copper loading states of SCO1 and SCO2 in cells — would directly test whether SCO1 is the copper-loaded donor species vs. SCO2.

  5. Crosslinking-MS of the COX2 metallation intermediate: Capture SCO1 in complex with COX2 during active copper transfer. Would demonstrate direct physical interaction during copper delivery and provide IDA-level evidence.

  6. Comparative GO annotation audit: Systematically compare SCO1 vs. SCO2 GO annotations across databases (UniProt-GOA, EBI, MGI) to identify and resolve inconsistencies in MF term assignment arising from paralog confusion.


Evidence Base: Key Literature

Foundational Papers

PMID: 15229189Human SCO1 and SCO2 have independent, cooperative functions in copper delivery to cytochrome c oxidase. Leary et al. (2004). This seminal paper established that SCO1 and SCO2 have "non-overlapping, cooperative functions in mitochondrial copper delivery." Through genetic complementation in human fibroblasts, it demonstrated that the two paralogs cannot substitute for each other, establishing functional specificity. This is the primary reference supporting the copper chaperone annotation upgrade.

PMID: 19336478Human SCO2 is required for the synthesis of CO II and as a thiol-disulphide oxidoreductase for SCO1. Leary et al. (2009). This paper provided the crucial pathway ordering: "SCO2 acts upstream of SCO1, and...it is indispensable for CO II synthesis," while SCO1 is required for COX2 copper metallation. This distinguishes SCO1's copper chaperone function from SCO2's oxidoreductase function and positions SCO1 as the direct copper donor — the strongest single piece of evidence for the GO:0016531 annotation.

PMID: 14604533Solution structure of Sco1: a thioredoxin-like protein involved in cytochrome c oxidase assembly. Balatri et al. (2003). The NMR structure of B. subtilis Sco1 provided the first atomic-resolution view of Cu(I) binding through the CxxxCP motif in a thioredoxin fold, establishing the structural basis for copper chaperone activity: "in vitro Sco1 binds copper(I) through a CXXXCP motif and possibly His 135."

Pathway and Complex Characterization

PMID: 32061935COA6 Facilitates Cytochrome c Oxidase Biogenesis as Thiol-reductase for Copper Metallochaperones in Mitochondria. Pacheu-Grau et al. (2020). Identified COA6 as a thiol-reductase for SCO1 and SCO2, defining the molecular complex that mediates copper delivery to COX2.

PMID: 29381136COX16 promotes COX2 metallation and assembly during respiratory complex IV biogenesis. Aich et al. (2018). Showed COX16 cooperates with the SCO pathway in COX2 metallation, providing additional pathway context.

PMID: 35981890 — Demonstrated that FKBP4 controls assembly of the COA6/SCO1/SCO2 complex, with disruption impairing COX biogenesis and activity.

Copper Homeostasis Dimension

PMID: 28973536The mitochondrial metallochaperone SCO1 maintains CTR1 at the plasma membrane to preserve copper homeostasis in the murine heart. Baker et al. (2017). Demonstrated that SCO1 maintains CTR1 at the plasma membrane in mouse cardiomyocytes: "the reduction in copper content of Sco1stm/stm cardiomyocytes was due to the mislocalisation of CTR1." Loss of SCO1 causes tissue-specific CTR1 mislocalization, revealing an additional function in copper homeostasis regulation.

PMID: 20136502 — Comprehensive review of redox regulation of SCO protein function, providing the framework for understanding how cysteine redox chemistry governs copper chaperone activity and links mitochondrial copper handling to cellular copper homeostasis signaling.

Disease Models and In Vivo Validation

PMID: 40679281 — Recent (2025) study using mouse knockin models of human SCO1 pathogenic variants, confirming tissue-specific COX and copper deficiency. Heart showed the most severe combined deficiency, "supporting the idea that the primary role of SCO1 in this tissue is to promote COX assembly."

PMID: 41621246 — Identified LRRK2 as a regulator of SCO1 redox status; pathogenic LRRK2 G2019S "increased the proportion of reduced (Cu-deficient) forms of COX11 and SCO1...thereby impairing COX assembly." Confirms the critical importance of SCO1's copper-bound redox state for its chaperone function and extends relevance to Parkinson's disease.

PMID: 19295170 — Showed that patient SCO1 G132S mutation severely decreases protein stability, that residual SCO1 migrates only as monomer (vs. normal higher-order complexes), that COX activity drops to 10–20% of control, and that "a fraction of Sco1 physically associates with the CcO complex in human muscle mitochondria." The physical association with COX suggests a direct role in copper delivery to the assembled or assembling complex.

Evolutionary Conservation

PMID: 20388558 — Characterized Drosophila melanogaster scox (single SCO ortholog). Null mutations cause lethality; SCO1 orthologs identified in 39 eukaryotic species. Conservation from bacteria to mammals supports GO:0016531 as an ancestral core function.

PMID: 15113935 — Review of intracellular copper transport establishing the canonical pathway: "Cox17 delivers copper to mitochondria to cytochrome c oxidase via the chaperones Cox11, Sco1, and Sco2."


Curation Leads

Lead 1: Upgrade GO:0016531 Evidence Code (HIGH PRIORITY)

  • Current: IEA (InterPro)
  • Proposed: IMP with reference to PMID: 15229189 and/or PMID: 19336478
  • Snippet to verify (PMID:15229189): "Our results demonstrate that the human SCO proteins have non-overlapping, cooperative functions in mitochondrial copper delivery."
  • Snippet to verify (PMID:19336478): "These results indicate that SCO2 acts upstream of SCO1, and that it is indispensable for CO II synthesis."
  • Rationale: Mutant SCO1 patient cells show defective copper delivery to COX; pathway ordering confirms SCO1 is the copper metallochaperone step.

Lead 2: Re-evaluate SCO2 GO:0016531 Annotation (MEDIUM PRIORITY)

  • Current: GO:0016531 (copper chaperone activity) for SCO2 (likely IEA)
  • Proposed action: Consider whether GO:0015036 (disulfide oxidoreductase activity) or a related term is more precise for SCO2's MF
  • Snippet to verify (PMID:19336478): "suggesting that SCO2 acts as a thiol-disulphide oxidoreductase to oxidize the copper-coordinating cysteines in SCO1 during CO II maturation"
  • Rationale: SCO2's direct molecular activity is oxidoreductase, not copper transfer.

Lead 3: Upgrade GO:0005507 Evidence (MEDIUM PRIORITY)

  • Current: IEA (InterPro)
  • Proposed: ISS with reference to PMID: 14604533 (bacterial ortholog)
  • Snippet to verify: "In vitro Sco1 binds copper(I) through a CXXXCP motif and possibly His 135"

Lead 4: Consider GO:0006878 with Experimental Evidence (LOW PRIORITY)

  • Current: IEA
  • Proposed: ISS or IMP with reference to PMID: 28973536 (mouse model)
  • Snippet to verify: "the reduction in copper content of Sco1stm/stm cardiomyocytes was due to the mislocalisation of CTR1, the high affinity transporter that imports copper into the cell"

Lead 5: Additional Supporting References

  • PMID: 41621246 (2025) — LRRK2 regulation of SCO1 redox state; confirms copper chaperone function relevance to PD.
  • PMID: 40679281 (2025) — Mouse knockin models of human SCO1 variants; confirms tissue-specific COX + copper deficiency.
  • PMID: 32061935 (2020) — COA6 as thiol-reductase for SCO1/SCO2; defines the copper relay complex.

Limitations

  1. Structural inference gap: No published Cu-bound structure of human SCO1 exists; copper binding is inferred from B. subtilis ortholog structure plus human mutagenesis data. The conservation is strong but falls short of IDA-quality evidence for the human protein specifically.

  2. IEA-only MF annotation: Despite abundant experimental evidence supporting copper chaperone activity, the GO MF annotation has not been upgraded from electronic inference, creating a disconnect between evidence quality and annotation status that this report aims to address.

  3. Copper homeostasis mechanism unclear: The pathway by which mitochondrial SCO1 signals to maintain plasma membrane CTR1 is not fully characterized in human cells; it is unclear whether this requires copper chaperone activity or represents an independent function.

  4. In vitro transfer not demonstrated: Direct copper transfer from purified human SCO1 to a COX2 substrate has not been reconstituted in vitro with kinetic measurements, which is the gold standard for a "chaperone" designation.

  5. Literature bias toward disease phenotypes: Much of the SCO1 literature focuses on disease consequences (cardiomyopathy, hepatopathy) rather than molecular mechanism, making it occasionally challenging to distinguish direct molecular function from downstream phenotypic effects. However, the key papers cited here do make this distinction clearly.

  6. SCO2 annotation not directly audited: This report focuses on SCO1; a comprehensive audit of SCO2's GO:0016531 annotation would require its own systematic review, though the evidence presented here strongly suggests re-evaluation is warranted.

📄 View Raw YAML

id: O75880
gene_symbol: SCO1
product_type: PROTEIN
status: COMPLETE
taxon:
  id: NCBITaxon:9606
  label: Homo sapiens
description: >-
  SCO1 is an inner mitochondrial membrane copper metallochaperone required for maturation of the CuA
  site of cytochrome c oxidase subunit II (MT-CO2/COX2). Together with SCO2 and other COX2-module
  factors, SCO1 participates in the mitochondrial copper relay that enables Complex IV assembly. SCO2
  appears to act upstream as a thiol-disulfide oxidoreductase affecting the redox state of SCO1's
  copper-coordinating cysteines, whereas SCO1 is best treated as the copper-handling/metallochaperone
  step for COX2 CuA-site maturation. SCO1 is an assembly factor rather than a structural subunit of
  mature Complex IV. It also has a secondary role in cellular copper homeostasis, including regulation
  of CTR1 abundance/localization. Pathogenic variants cause mitochondrial Complex IV deficiency,
  nuclear type 4.
existing_annotations:
  - term:
      id: GO:0005507
      label: copper ion binding
    evidence_type: IEA
    original_reference_id: GO_REF:0000002
    qualifier: enables
    review:
      summary: >-
        SCO1 binds copper through conserved SCO-family metal-binding residues as part of the mitochondrial
        copper relay for COX2 CuA-site maturation.
      action: ACCEPT
      reason: >-
        Core biochemical property supporting copper chaperone activity. The existing annotation is IEA,
        but patient-cell and pathway-ordering evidence support the functional importance of the CxxxC
        copper-coordinating motif in SCO1-dependent COX2 maturation.
      additional_reference_ids:
        - PMID:19336478
        - file:human/SCO1/SCO1-deep-research-falcon.md
      supported_by:
        - reference_id: PMID:19336478
          supporting_text: >-
            The subsequent maturation of CO II is contingent upon the formation of a complex that includes
            both SCO proteins, each with a functional CxxxC copper-coordinating motif.
        - reference_id: file:human/SCO1/SCO1-deep-research-falcon.md
          supporting_text: >-
            SCO1 has a thioredoxin-like fold and a copper-binding CxxxC motif characteristic of SCO-family
            proteins; available context states that cysteine-based copper binding requires the cysteines
            to remain reduced.
  - term:
      id: GO:0005743
      label: mitochondrial inner membrane
    evidence_type: IEA
    original_reference_id: GO_REF:0000120
    qualifier: located_in
    review:
      summary: >-
        SCO1 is a single-pass mitochondrial inner membrane protein with its functional domain exposed
        for COX2 maturation.
      action: ACCEPT
      reason: >-
        Correct core localization.
      supported_by:
        - reference_id: file:human/SCO1/SCO1-deep-research-falcon.md
          supporting_text: >-
            Human SCO1 is described as a mitochondrial inner membrane transmembrane protein with a short
            N-terminal matrix-facing tail and most of the polypeptide exposed to the IMS, consistent with
            its role in receiving copper from IMS-localized COX17 and delivering copper to the IMS-facing
            domain of COX2.
  - term:
      id: GO:0006878
      label: intracellular copper ion homeostasis
    evidence_type: IEA
    original_reference_id: GO_REF:0000002
    qualifier: involved_in
    review:
      summary: >-
        SCO1 participates in copper handling and has reported effects on cellular copper homeostasis,
        but its primary evolved role is copper delivery during Complex IV assembly.
      action: KEEP_AS_NON_CORE
      reason: >-
        Keep as a valid secondary function, not the core annotation. Falcon-summarized 2023-2024 work
        in hepatocyte-specific Sco1 loss models links SCO1 deficiency to hepatic copper deficiency,
        elevated circulating copper/ceruloplasmin, and copper-dependent immunosuppression signaling,
        supporting a real but secondary role in systemic copper homeostasis.
      additional_reference_ids:
        - file:human/SCO1/SCO1-deep-research-falcon.md
      supported_by:
        - reference_id: file:human/SCO1/SCO1-deep-research-falcon.md
          supporting_text: >-
            2023-2024 work links hepatocyte-specific Sco1 loss to hepatic copper deficiency, elevated
            circulating copper/ceruloplasmin, AFP-dependent copper-requiring immunosuppression, and
            bone-marrow lymphoid progenitor defects, expanding SCO1 biology from complex IV metallation
            to systemic pathophysiology in mitochondrial disease models.
  - term:
      id: GO:0008535
      label: respiratory chain complex IV assembly
    evidence_type: IEA
    original_reference_id: GO_REF:0000002
    qualifier: involved_in
    review:
      summary: >-
        SCO1 is required for respiratory chain Complex IV assembly through COX2 copper-site maturation.
      action: ACCEPT
      reason: >-
        Correct biological-process annotation.
      supported_by:
        - reference_id: file:human/SCO1/SCO1-deep-research-falcon.md
          supporting_text: >-
            SCO1 is the COX2-specific copper metallochaperone for cytochrome c oxidase/complex IV
            biogenesis. Current understanding is that it inserts copper into the CuA site of COX2 rather
            than catalyzing a classic enzyme reaction; its role is metallation/assembly, with redox
            competence of cysteines required for function.
  - term:
      id: GO:0016531
      label: copper chaperone activity
    evidence_type: IEA
    original_reference_id: GO_REF:0000002
    qualifier: enables
    review:
      summary: >-
        SCO1 functions as a copper chaperone/metallochaperone in the COX2 CuA-site maturation pathway.
      action: ACCEPT
      reason: >-
        Core molecular function. OpenScientist review of the focused core-function hypothesis judged
        this term supported, while highlighting that the current GOA term is IEA-only and should be
        upgraded or complemented with experimental support from patient-cell studies and pathway-ordering
        work.
      additional_reference_ids:
        - PMID:15229189
        - PMID:19336478
        - file:human/SCO1/SCO1-hypotheses/core-function-1-go-0016531/openscientist.md
        - file:human/SCO1/SCO1-deep-research-falcon.md
      supported_by:
        - reference_id: PMID:15229189
          supporting_text: >-
            Our results demonstrate that the human SCO proteins have non-overlapping, cooperative
            functions in mitochondrial copper delivery.
        - reference_id: PMID:19336478
          supporting_text: >-
            Based on these data we present a model in which each SCO protein fulfills distinct,
            stage-specific functions during CO II synthesis and CuA site maturation.
        - reference_id: file:human/SCO1/SCO1-hypotheses/core-function-1-go-0016531/openscientist.md
          supporting_text: >-
            OpenScientist judged copper chaperone activity (GO:0016531) to be supported as a core
            molecular function of SCO1 and recommended upgrading the IEA-only molecular-function support.
        - reference_id: file:human/SCO1/SCO1-deep-research-falcon.md
          supporting_text: >-
            Across recent reviews, SCO1 is described as a COX2-specific copper metallochaperone required
            for insertion of copper into the CuA site of COX2 during complex IV assembly. SCO1 is not
            described as catalyzing a small-molecule reaction; instead, its functional output is metal
            delivery/metallation and enabling maturation of complex IV.
  - term:
      id: GO:0033617
      label: mitochondrial respiratory chain complex IV assembly
    evidence_type: IEA
    original_reference_id: GO_REF:0000117
    qualifier: involved_in
    review:
      summary: >-
        SCO1 participates specifically in mitochondrial respiratory chain Complex IV assembly.
      action: ACCEPT
      reason: >-
        Correct and appropriately specific biological-process annotation.
      supported_by:
        - reference_id: file:human/SCO1/SCO1-deep-research-falcon.md
          supporting_text: >-
            Recent reviews converge on a mechanistic consensus that SCO1 is a core CuA-site
            metallochaperone operating at the IMS face of the inner membrane, receiving copper from
            COX17 and cooperating with SCO2/COA6-driven redox processes to enable copper insertion into
            COX2 and thus complex IV maturation.
  - term:
      id: GO:0005515
      label: protein binding
    evidence_type: IPI
    original_reference_id: PMID:18458339
    qualifier: enables
    review:
      summary: >-
        The protein-binding annotations report physical interactions among COX2-module assembly factors
        or broad interactome hits. These do not define SCO1's function.
      action: MARK_AS_OVER_ANNOTATED
      reason: >-
        Generic protein binding is less informative than copper chaperone activity and Complex IV
        assembly; mark as over-annotated rather than core.
  - term:
      id: GO:0005515
      label: protein binding
    evidence_type: IPI
    original_reference_id: PMID:29568061
    qualifier: enables
    review:
      summary: >-
        The protein-binding annotations report physical interactions among COX2-module assembly factors
        or broad interactome hits. These do not define SCO1's function.
      action: MARK_AS_OVER_ANNOTATED
      reason: >-
        Generic protein binding is less informative than copper chaperone activity and Complex IV
        assembly; mark as over-annotated rather than core.
  - term:
      id: GO:0005515
      label: protein binding
    evidence_type: IPI
    original_reference_id: PMID:32296183
    qualifier: enables
    review:
      summary: >-
        The protein-binding annotations report physical interactions among COX2-module assembly factors
        or broad interactome hits. These do not define SCO1's function.
      action: MARK_AS_OVER_ANNOTATED
      reason: >-
        Generic protein binding is less informative than copper chaperone activity and Complex IV
        assembly; mark as over-annotated rather than core.
  - term:
      id: GO:0005515
      label: protein binding
    evidence_type: IPI
    original_reference_id: PMID:32814053
    qualifier: enables
    review:
      summary: >-
        The protein-binding annotations report physical interactions among COX2-module assembly factors
        or broad interactome hits. These do not define SCO1's function.
      action: MARK_AS_OVER_ANNOTATED
      reason: >-
        Generic protein binding is less informative than copper chaperone activity and Complex IV
        assembly; mark as over-annotated rather than core.
  - term:
      id: GO:0005739
      label: mitochondrion
    evidence_type: IEA
    original_reference_id: GO_REF:0000107
    qualifier: located_in
    review:
      summary: >-
        SCO1 is a mitochondrial Complex IV assembly factor.
      action: ACCEPT
      reason: >-
        Correct broad localization; mitochondrial inner membrane is more specific.
  - term:
      id: GO:0005739
      label: mitochondrion
    evidence_type: HTP
    original_reference_id: PMID:34800366
    qualifier: located_in
    review:
      summary: >-
        SCO1 is a mitochondrial Complex IV assembly factor.
      action: ACCEPT
      reason: >-
        Correct broad localization; mitochondrial inner membrane is more specific.
      supported_by:
        - reference_id: file:human/SCO1/SCO1-uniprot.txt
          supporting_text: >-
            SUBCELLULAR LOCATION: Mitochondrion
  - term:
      id: GO:0005743
      label: mitochondrial inner membrane
    evidence_type: TAS
    original_reference_id: Reactome:R-HSA-9865449
    qualifier: located_in
    review:
      summary: >-
        SCO1 is a single-pass mitochondrial inner membrane protein with its functional domain exposed
        for COX2 maturation.
      action: ACCEPT
      reason: >-
        Correct core localization.
  - term:
      id: GO:0005743
      label: mitochondrial inner membrane
    evidence_type: TAS
    original_reference_id: Reactome:R-HSA-9865579
    qualifier: located_in
    review:
      summary: >-
        SCO1 is a single-pass mitochondrial inner membrane protein with its functional domain exposed
        for COX2 maturation.
      action: ACCEPT
      reason: >-
        Correct core localization.
  - term:
      id: GO:0005743
      label: mitochondrial inner membrane
    evidence_type: TAS
    original_reference_id: Reactome:R-HSA-9865630
    qualifier: located_in
    review:
      summary: >-
        SCO1 is a single-pass mitochondrial inner membrane protein with its functional domain exposed
        for COX2 maturation.
      action: ACCEPT
      reason: >-
        Correct core localization.
  - term:
      id: GO:0005739
      label: mitochondrion
    evidence_type: IDA
    original_reference_id: PMID:9878253
    qualifier: located_in
    review:
      summary: >-
        SCO1 is a mitochondrial Complex IV assembly factor.
      action: ACCEPT
      reason: >-
        Correct broad localization; mitochondrial inner membrane is more specific.
      supported_by:
        - reference_id: file:human/SCO1/SCO1-uniprot.txt
          supporting_text: >-
            SUBCELLULAR LOCATION: Mitochondrion inner membrane
  - term:
      id: GO:0005515
      label: protein binding
    evidence_type: IPI
    original_reference_id: PMID:29381136
    qualifier: enables
    review:
      summary: >-
        The protein-binding annotations report physical interactions among COX2-module assembly factors
        or broad interactome hits. These do not define SCO1's function.
      action: MARK_AS_OVER_ANNOTATED
      reason: >-
        Generic protein binding is less informative than copper chaperone activity and Complex IV
        assembly; mark as over-annotated rather than core.
  - term:
      id: GO:0033617
      label: mitochondrial respiratory chain complex IV assembly
    evidence_type: IMP
    original_reference_id: PMID:15229189
    qualifier: involved_in
    review:
      summary: >-
        SCO1 participates specifically in mitochondrial respiratory chain Complex IV assembly.
      action: ACCEPT
      reason: >-
        Correct and appropriately specific biological-process annotation.
      supported_by:
        - reference_id: file:human/SCO1/SCO1-deep-research-falcon.md
          supporting_text: >-
            SCO1 is described as a COX2-specific copper metallochaperone required for insertion of
            copper into the CuA site of COX2 during complex IV assembly.
  - term:
      id: GO:0005743
      label: mitochondrial inner membrane
    evidence_type: IDA
    original_reference_id: PMID:15229189
    qualifier: located_in
    review:
      summary: >-
        SCO1 is a single-pass mitochondrial inner membrane protein with its functional domain exposed
        for COX2 maturation.
      action: ACCEPT
      reason: >-
        Correct core localization.
      supported_by:
        - reference_id: file:human/SCO1/SCO1-deep-research-falcon.md
          supporting_text: >-
            Human SCO1 is described as a mitochondrial inner membrane transmembrane protein with a short
            N-terminal matrix-facing tail and most of the polypeptide exposed to the IMS
  - term:
      id: GO:0005515
      label: protein binding
    evidence_type: IPI
    original_reference_id: PMID:24403053
    qualifier: enables
    review:
      summary: >-
        The protein-binding annotations report physical interactions among COX2-module assembly factors
        or broad interactome hits. These do not define SCO1's function.
      action: MARK_AS_OVER_ANNOTATED
      reason: >-
        Generic protein binding is less informative than copper chaperone activity and Complex IV
        assembly; mark as over-annotated rather than core.
  - term:
      id: GO:0005515
      label: protein binding
    evidence_type: IPI
    original_reference_id: PMID:28330871
    qualifier: enables
    review:
      summary: >-
        The protein-binding annotations report physical interactions among COX2-module assembly factors
        or broad interactome hits. These do not define SCO1's function.
      action: MARK_AS_OVER_ANNOTATED
      reason: >-
        Generic protein binding is less informative than copper chaperone activity and Complex IV
        assembly; mark as over-annotated rather than core.
  - term:
      id: GO:0005515
      label: protein binding
    evidence_type: IPI
    original_reference_id: PMID:29154948
    qualifier: enables
    review:
      summary: >-
        The protein-binding annotations report physical interactions among COX2-module assembly factors
        or broad interactome hits. These do not define SCO1's function.
      action: MARK_AS_OVER_ANNOTATED
      reason: >-
        Generic protein binding is less informative than copper chaperone activity and Complex IV
        assembly; mark as over-annotated rather than core.
  - term:
      id: GO:0005515
      label: protein binding
    evidence_type: IPI
    original_reference_id: PMID:26160915
    qualifier: enables
    review:
      summary: >-
        The protein-binding annotations report physical interactions among COX2-module assembly factors
        or broad interactome hits. These do not define SCO1's function.
      action: MARK_AS_OVER_ANNOTATED
      reason: >-
        Generic protein binding is less informative than copper chaperone activity and Complex IV
        assembly; mark as over-annotated rather than core.
  - term:
      id: GO:0030016
      label: myofibril
    evidence_type: IDA
    original_reference_id: PMID:20864674
    qualifier: located_in
    review:
      summary: >-
        The myofibril annotation reflects reported localization/enrichment in a tissue context but
        does not describe SCO1's primary mitochondrial assembly-factor role.
      action: KEEP_AS_NON_CORE
      reason: >-
        Keep as non-core pending stronger mechanistic interpretation.
core_functions:
  - description: >-
      SCO1 is a mitochondrial copper chaperone/assembly factor that helps deliver copper to the CuA
      site of MT-CO2 during Complex IV biogenesis. Its core function is not mature Complex IV catalysis,
      but copper handling within the COX2 maturation pathway. Evidence from SCO1 and SCO2 patient-cell
      studies supports distinct, stage-specific roles: SCO2 acts upstream in CO II synthesis/redox
      control, while SCO1 is required for the copper-dependent maturation step.
    molecular_function:
      id: GO:0016531
      label: copper chaperone activity
    directly_involved_in:
      - id: GO:0033617
        label: mitochondrial respiratory chain complex IV assembly
    locations:
      - id: GO:0005743
        label: mitochondrial inner membrane
    supported_by:
      - reference_id: PMID:15229189
        supporting_text: >-
          Our results demonstrate that the human SCO proteins have non-overlapping, cooperative functions
          in mitochondrial copper delivery.
      - reference_id: PMID:19336478
        supporting_text: >-
          Based on these data we present a model in which each SCO protein fulfills distinct,
          stage-specific functions during CO II synthesis and CuA site maturation.
      - reference_id: file:human/SCO1/SCO1-hypotheses/core-function-1-go-0016531/openscientist.md
        supporting_text: >-
          The focused OpenScientist hypothesis review found the SCO1 copper chaperone core-function
          hypothesis supported and identified IEA-only GO:0016531 support as the main curation gap.
      - reference_id: file:human/SCO1/SCO1-uniprot.txt
        supporting_text: >-
          Copper metallochaperone essential for the maturation of cytochrome c oxidase subunit II
          (MT-CO2/COX2). Together with SCO2, involved in delivering copper to the Cu(A) site on MT-CO2/COX2.
      - reference_id: file:human/SCO1/SCO1-deep-research-falcon.md
        supporting_text: |-
          Across recent reviews, SCO1 is described as a COX2-specific copper metallochaperone required
          for insertion of copper into the CuA site of COX2 during complex IV assembly. SCO1 is not
          described as catalyzing a small-molecule reaction; instead, its functional output is metal
          delivery/metallation and enabling maturation of complex IV.
      - reference_id: file:human/SCO1/SCO1-deep-research-falcon.md
        supporting_text: >-
          Human SCO1 is described as a mitochondrial inner membrane transmembrane protein with a short
          N-terminal matrix-facing tail and most of the polypeptide exposed to the IMS, consistent with
          its role in receiving copper from IMS-localized COX17 and delivering copper to the IMS-facing
          domain of COX2.
references:
  - id: GO_REF:0000002
    title: Gene Ontology annotation through association of InterPro records with GO terms
    findings: []
  - id: GO_REF:0000107
    title: Automatic transfer of experimentally verified manual GO annotation data to orthologs
      using Ensembl Compara
    findings: []
  - id: GO_REF:0000117
    title: Electronic Gene Ontology annotations created by ARBA machine learning models
    findings: []
  - id: GO_REF:0000120
    title: Combined Automated Annotation using Multiple IEA Methods
    findings: []
  - id: PMID:15229189
    title: Human SCO1 and SCO2 have independent, cooperative functions in copper delivery to
      cytochrome c oxidase.
    findings: []
  - id: PMID:19336478
    title: Human SCO2 is required for the synthesis of CO II and as a thiol-disulphide
      oxidoreductase for SCO1.
    findings:
      - statement: SCO2 acts upstream of SCO1 and is required for CO II synthesis.
      - statement: SCO1 and SCO2 fulfill distinct, stage-specific functions during CO II synthesis
          and CuA site maturation.
      - statement: The redox state of SCO1 copper-coordinating cysteines is perturbed in SCO1
          and SCO2 patient-cell backgrounds.
  - id: file:human/SCO1/SCO1-hypotheses/core-function-1-go-0016531/openscientist.md
    title: OpenScientist focused review of SCO1 copper chaperone activity as a core function
    findings:
      - statement: The SCO1 copper chaperone activity core-function hypothesis was judged supported.
      - statement: The current GO:0016531 annotation is biologically correct but IEA-only in GOA.
      - statement: PMID:15229189 and PMID:19336478 were prioritized as evidence for experimental
          support of SCO1 copper handling in COX2 maturation.
      - statement: SCO2 should be considered for a separate follow-up audit because its direct role
          may be better described as upstream thiol-disulfide oxidoreductase activity.
  - id: PMID:18458339
    title: Mitochondrial copper(I) transfer from Cox17 to Sco1 is coupled to electron transfer.
    findings: []
  - id: PMID:20864674
    title: 'Unexpected vascular enrichment of SCO1 over SCO2 in mammalian tissues: implications for
      human mitochondrial disease.'
    findings: []
  - id: PMID:24403053
    title: Human COX20 cooperates with SCO1 and SCO2 to mature COX2 and promote the assembly of
      cytochrome c oxidase.
    findings: []
  - id: PMID:26160915
    title: COA6 is a mitochondrial complex IV assembly factor critical for biogenesis of
      mtDNA-encoded COX2.
    findings: []
  - id: PMID:28330871
    title: Human mitochondrial cytochrome c oxidase assembly factor COX18 acts transiently as a
      membrane insertase within the subunit 2 maturation module.
    findings: []
  - id: PMID:29154948
    title: The mitochondrial TMEM177 associates with COX20 during COX2 biogenesis.
    findings: []
  - id: PMID:29381136
    title: COX16 promotes COX2 metallation and assembly during respiratory complex IV
      biogenesis.
    findings: []
  - id: PMID:29568061
    title: An AP-MS- and BioID-compatible MAC-tag enables comprehensive mapping of protein
      interactions and subcellular localizations.
    findings: []
  - id: PMID:32296183
    title: A reference map of the human binary protein interactome.
    findings: []
  - id: PMID:32814053
    title: Interactome Mapping Provides a Network of Neurodegenerative Disease Proteins and
      Uncovers Widespread Protein Aggregation in Affected Brains.
    findings: []
  - id: PMID:34800366
    title: Quantitative high-confidence human mitochondrial proteome and its dynamics in
      cellular context.
    findings: []
  - id: PMID:9878253
    title: Identification and characterization of human cDNAs specific to BCS1, PET112, SCO1,
      COX15, and COX11, five genes involved in the formation and function of the mitochondrial
      respiratory chain.
    findings: []
  - id: Reactome:R-HSA-9865449
    title: Metallochaperone inserts Cu2+ into MT-CO1
    findings: []
  - id: Reactome:R-HSA-9865579
    title: MT-CO1 and MT-CO2 complexes associate, installing heme moieties
    findings: []
  - id: Reactome:R-HSA-9865630
    title: Metallochaperone inserts 2Cu2+ into MT-CO2
    findings: []
  - id: file:human/SCO1/SCO1-deep-research-falcon.md
    title: Falcon (Edison) deep-research report on human SCO1 (O75880)
    findings:
      - statement: SCO1 is the COX2-specific copper metallochaperone required for insertion of
          copper into the CuA site of COX2 during complex IV assembly; its functional output is
          metal delivery/metallation, not catalysis of a small-molecule reaction.
        supporting_text: >-
          Across recent reviews, SCO1 is described as a COX2-specific copper metallochaperone required
          for insertion of copper into the CuA site of COX2 during complex IV assembly. SCO1 is not
          described as catalyzing a small-molecule reaction; instead, its functional output is metal
          delivery/metallation and enabling maturation of complex IV.
        reference_section_type: OTHER
      - statement: Human SCO1 is an inner mitochondrial membrane protein with a short
          N-terminal matrix-facing tail and the bulk of the polypeptide exposed to the IMS,
          positioning its functional domain for COX2 CuA-site maturation.
        supporting_text: >-
          Human SCO1 is described as a mitochondrial inner membrane transmembrane protein with a short
          N-terminal matrix-facing tail and most of the polypeptide exposed to the IMS, consistent with
          its role in receiving copper from IMS-localized COX17 and delivering copper to the IMS-facing
          domain of COX2.
        reference_section_type: OTHER
      - statement: SCO1 has a thioredoxin-like fold and a conserved CxxxC copper-binding motif;
          cysteine-based copper binding requires the cysteines to remain reduced.
        supporting_text: >-
          SCO1 has a thioredoxin-like fold and a copper-binding CxxxC motif characteristic of SCO-family
          proteins; available context states that cysteine-based copper binding requires the cysteines
          to remain reduced.
        reference_section_type: OTHER
      - statement: SCO2 and COA6 act as disulfide reductases/thiol-redox factors that keep SCO1
          (and/or COX2) in a copper-binding competent state, coupling redox and copper handling.
        supporting_text: >-
          The IMS copper-handling network requires redox regulation: SCO2 and COA6 are described as
          acting as disulfide reductases/thiol-redox factors that maintain SCO1 (and/or COX2) in a
          copper-binding competent state.
        reference_section_type: OTHER
      - statement: A current model proposes that SCO1 and SCO2 can form a ternary complex with
          apo-COX2 in which each SCO protein donates a single copper ion to build the binuclear CuA
          center.
        supporting_text: >-
          A recent synthesis emphasizes that in humans SCO1 and SCO2 can form a ternary complex with
          apo-COX2, with each SCO protein proposed to donate a single copper ion to build the binuclear
          CuA center.
        reference_section_type: OTHER
      - statement: Mechanistic consensus places SCO1 at the IMS face of the inner membrane,
          receiving copper from COX17 and cooperating with SCO2/COA6-driven redox processes to enable
          copper insertion into COX2 and Complex IV maturation.
        supporting_text: >-
          Recent reviews converge on a mechanistic consensus that SCO1 is a core CuA-site
          metallochaperone operating at the IMS face of the inner membrane, receiving copper from
          COX17 and cooperating with SCO2/COA6-driven redox processes to enable copper insertion into
          COX2 and thus complex IV maturation.
        reference_section_type: OTHER
      - statement: SCO1 deficiency causes severe neonatal/infantile mitochondrial disease with
          isolated/predominant complex IV deficiency, including hypertrophic cardiomyopathy, hepatic
          failure, encephalopathy/brain atrophy, and lactic acidosis; reported variants include V93X,
          G132S, P174L, and M294V.
        supporting_text: >-
          Human SCO1 deficiency causes severe neonatal/infantile mitochondrial disease with isolated or
          predominant complex IV deficiency. Reported phenotypes include neonatal hepatic failure,
          lactic acidosis, hypertrophic cardiomyopathy/ventricular hypertrophy, hepatomegaly,
          encephalopathy/brain atrophy, and fatal infantile cardio-hepatic-neurologic disease. Variants
          reported in context include V93X, G132S, P174L, and M294V.
        reference_section_type: OTHER
      - statement: The P174L pathogenic variant lies adjacent to the copper-binding region and, in
          yeast modeling, impairs copper transfer from COX17 despite preserved copper binding,
          consistent with a defect in copper handoff rather than complete loss of copper binding.
        supporting_text: >-
          For example, the P174L variant is described as adjacent to the copper-binding region and, in
          yeast modeling, it impairs copper transfer from COX17 despite normal copper binding,
          supporting a specific defect in copper handoff rather than complete loss of copper binding.
        reference_section_type: OTHER
      - statement: 2023-2024 work in hepatocyte-specific Sco1 loss models links SCO1 deficiency
          to hepatic copper deficiency, elevated circulating copper/ceruloplasmin, AFP-dependent
          copper-requiring immunosuppression, and bone-marrow lymphoid progenitor defects, extending
          SCO1 biology from local Complex IV metallation to systemic copper-linked signaling.
        supporting_text: >-
          2023-2024 work links hepatocyte-specific Sco1 loss to hepatic copper deficiency, elevated
          circulating copper/ceruloplasmin, AFP-dependent copper-requiring immunosuppression, and
          bone-marrow lymphoid progenitor defects, expanding SCO1 biology from complex IV metallation
          to systemic pathophysiology in mitochondrial disease models.
        reference_section_type: OTHER
proposed_new_terms: []
suggested_questions:
  - question: Should GO add or request an experimental human SCO1 annotation to GO:0016531
      based on PMID:15229189 and PMID:19336478, rather than leaving the molecular-function
      support as IEA-only?
  - question: Does the evidence for SCO2 support retaining copper chaperone activity, or should
      SCO2 be reviewed separately as an upstream thiol-disulfide oxidoreductase acting on SCO1?
  - question: Is there direct human biochemical evidence for copper transfer from purified SCO1
      to a COX2 CuA-site substrate, or should SCO1 copper chaperone activity remain supported
      primarily by IMP/pathway-ordering evidence?
suggested_experiments:
  - description: Reconstitute copper transfer from purified human SCO1 to a COX2 CuA-site substrate
      or COX2 maturation module, with CxxxC/His-site mutants as negative controls.
    experiment_type: in vitro copper-transfer assay
    hypothesis: SCO1 directly transfers copper to the COX2 CuA-site maturation intermediate.
  - description: Perform rescue experiments in SCO1-deficient human cells with wild-type SCO1 and
      copper-coordinating motif mutants, measuring COX2 metallation, Complex IV assembly, and COX
      activity separately.
    experiment_type: CRISPR rescue and mitochondrial biogenesis assay
    hypothesis: SCO1's copper-coordinating motif is required for COX2 metallation rather than only
      for SCO1 stability or protein-protein interaction.